<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30123106</article-id>
<article-id pub-id-type="pmc">6085424</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00270</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Teresa H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/175916/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Binder</surname>
<given-names>Devin K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ethell</surname>
<given-names>Iryna M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Razak</surname>
<given-names>Khaleel A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/10015/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Neuroscience Graduate Program, University of California, Riverside</institution>, <addr-line>Riverside, CA</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Division of Biomedical Sciences, School of Medicine, University of California, Riverside</institution>, <addr-line>Riverside, CA</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Psychology Graduate Program, Department of Psychology, University of California, Riverside</institution>, <addr-line>Riverside, CA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Michele Papa, Università degli Studi della Campania Luigi Vanvitelli” Caserta, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Wolfgang Härtig, Leipzig University, Germany; Giovanni Cirillo, Università degli Studi della Campania “Luigi Vanvitelli” Naples, Italy; Michael Fox, Virginia Tech Carilion Research Institute, United States</p>
</fn>
<corresp id="c001">*Correspondence: Iryna M. Ethell, <email>iryna.ethell@medsch.ucr.edu</email> Khaleel A. Razak, <email>khaleel@ucr.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>270</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Wen, Binder, Ethell and Razak.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Wen, Binder, Ethell and Razak</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Perineuronal nets (PNN) are extracellular matrix (ECM) assemblies that preferentially ensheath parvalbumin (PV) expressing interneurons. Converging evidence indicates that PV cells and PNN are impaired in a variety of neurological disorders. PNN development and maintenance is necessary for a number of processes within the CNS, including regulation of GABAergic cell function, protection of neurons from oxidative stress, and closure of developmental critical period plasticity windows. Understanding PNN functions may be essential for characterizing the mechanisms of altered cortical excitability observed in neurodegenerative and neurodevelopmental disorders. Indeed, PNN abnormalities have been observed in post-mortem brain tissues of patients with schizophrenia and Alzheimer’s disease. There is impaired development of PNNs and enhanced activity of its key regulator matrix metalloproteinase-9 (MMP-9) in Fragile X Syndrome, a common genetic cause of autism. MMP-9, a protease that cleaves ECM, is differentially regulated in a number of these disorders. Despite this, few studies have addressed the interactions between PNN expression, MMP-9 activity and neuronal excitability. In this review, we highlight the current evidence for PNN abnormalities in CNS disorders associated with altered network function and MMP-9 levels, emphasizing the need for future work targeting PNNs in pathophysiology and therapeutic treatment of neurological disorders.</p>
</abstract>
<kwd-group>
<kwd>perineuronal nets</kwd>
<kwd>extracellular matrix</kwd>
<kwd>interneurons</kwd>
<kwd>excitation/inhibition balance</kwd>
<kwd>sensory cortex</kwd>
<kwd>Fragile X Syndrome</kwd>
<kwd>autism</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
<award-id rid="cn001">U54 HD082008</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="214"></ref-count>
<page-count count="17"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>First described by Golgi and Cajal (<xref ref-type="bibr" rid="B73">Golgi, 1893</xref>; <xref ref-type="bibr" rid="B162">Ramón and Cajal, 1897</xref>), PNNs are assemblies of ECM proteins, which form net-like structures around neurons (<xref ref-type="bibr" rid="B22">Brauer et al., 1982</xref>, <xref ref-type="bibr" rid="B21">1984</xref>). While PNNs were first identified in the late 1800s, much of our current knowledge about PNN structure and function can be attributed to a renewed interest in PNNs almost a century later (<xref ref-type="bibr" rid="B25">Brückner et al., 1993</xref>; <xref ref-type="bibr" rid="B36">Celio and Blümcke, 1994</xref>; <xref ref-type="bibr" rid="B37">Celio et al., 1998</xref>). Since then, PNNs have been implicated in a wide range of functions including neuroprotection, regulation of neural activity and experience-dependent plasticity. Excellent reviews have been written about the role of PNNs in brain development (<xref ref-type="bibr" rid="B10">Berardi et al., 2004</xref>; <xref ref-type="bibr" rid="B88">Hensch, 2005</xref>; <xref ref-type="bibr" rid="B96">Karetko and Skangiel-Kramska, 2009</xref>; <xref ref-type="bibr" rid="B203">Wang and Fawcett, 2012</xref>). Recently, increasing evidence suggests that PNNs are altered in various neurodevelopmental and neurodegenerative disorders associated with changes in brain activity (<xref ref-type="bibr" rid="B48">De Luca and Papa, 2016</xref>; <xref ref-type="bibr" rid="B185">Sorg et al., 2016</xref>; <xref ref-type="bibr" rid="B78">Härtig et al., 2016</xref>). In parallel, a number of these CNS diseases exhibit dysregulated expression of enzymes necessary for PNN cleavage and reorganization (<xref ref-type="bibr" rid="B5">Backstrom et al., 1996</xref>; <xref ref-type="bibr" rid="B116">Lorenzl et al., 2003</xref>; <xref ref-type="bibr" rid="B173">Rybakowski et al., 2009</xref>; <xref ref-type="bibr" rid="B99">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="B214">Zhang et al., 2011</xref>; <xref ref-type="bibr" rid="B211">Yamamori et al., 2013</xref>; <xref ref-type="bibr" rid="B115">Liu et al., 2014</xref>; <xref ref-type="bibr" rid="B163">Rankin-Gee et al., 2015</xref>; <xref ref-type="bibr" rid="B111">Lepeta et al., 2017</xref>). However, the role of PNNs in neural and network excitability is only beginning to be understood (<xref ref-type="bibr" rid="B7">Balmer, 2016</xref>; <xref ref-type="bibr" rid="B139">Murase et al., 2017</xref>; <xref ref-type="bibr" rid="B206">Wen et al., 2017</xref>). Based on evidence from recent studies in the mouse model of FXS, we propose a novel working hypothesis in which MMP-9 mediated cleavage and/or reorganization of PNN structures around PV-expressing cells contributes to abnormal PV cell development and cortical hyperexcitability (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). Using this hypothesis as a scaffold, we bring together evidence from studies of schizophrenia, AD, and epilepsy to suggest that systematic studies of the interplay between MMP-9, PNN and PV cells may be key to understanding mechanisms of multiple CNS disorders at the cellular and circuit levels.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Working hypothesis in which MMP-9 is necessary for normal PV cell function and consequently normal neuronal and network excitability <bold>(A)</bold>. Top row: schematic of PV/PNN cells and cleavage of PNN by MMP-9. Middle row: single unit responses (each vertical line is an action potential in the post-stimulus time histogram) to sound stimulus (black bar under the abscissa) and spectral power of baseline EEGs. <bold>(B)</bold> Increased MMP-9 levels in disorders such as Fragile X Syndrome cause altered PNN formation/composition around PV cells. This may contribute to increased response to sensory stimuli and enhanced gamma power in baseline EEGs. The review argues that multiple neurological and neurodevelopmental disorders may include altered PV/PNN/MMP-9 interactions leading to circuit dysfunction. PV, parvalbumin; PNN, perineuronal nets; MMP-9, matrix metalloproteinase-9.</p>
</caption>
<graphic xlink:href="fnmol-11-00270-g001"></graphic>
</fig>
</sec>
<sec>
<title>PNN Structure and Developmental Regulation of its Components</title>
<p>Perineuronal nets are specialized assemblies of ECM proteins which ensheath neurons and proximal dendrites (<xref ref-type="bibr" rid="B37">Celio et al., 1998</xref>). PNNs are composed of CSPGs, tenascin, and link proteins, which facilitate binding to a hyaluronan backbone (<xref ref-type="bibr" rid="B210">Yamaguchi, 1999</xref>) (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). Developmental regulation of ECM proteins, which make up PNNs, may underlie PNN formation, composition, and function (<xref ref-type="bibr" rid="B101">Köppe et al., 1997</xref>). The developmental changes in major PNN proteins are discussed in the following sections:</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Structural composition of PNN. Lecticans are attached to a hyaluronan backbone via link proteins such as cartilage link protein and hyaluronan link proteins (<italic>not pictured</italic>). Hyaluronan synthase contributes to hyaluronan synthesis and anchors hyaluronan to the cell membrane. Tenascin promotes crosslinking of lecticans and helps maintain PNN structural integrity. PNN around PV cells may provide protection from redox dysregulation and oxidative stressors such as superoxide free radicals (O<sub>2</sub><sup>-</sup>) and metal ions (Fe). In addition, PNNs may facilitate PV maturation through internalization of Otx2 homeoproteins and regulate PV cell excitability through accumulation of the immediate early gene and synaptic scaling molecule <italic>Narp</italic> (see <italic>Fragile X Syndrome</italic>). Narp, neuronal activity-regulated pentraxin; Otx2, orthodenticle homeoprotein 2.</p>
</caption>
<graphic xlink:href="fnmol-11-00270-g002"></graphic>
</fig>
<sec>
<title>Chondroitin Sulfate Proteoglycans</title>
<p>Chondroitin sulfate proteoglycans consist of a core protein and varying amounts of chondroitin sulfate chains covalently bound to a central region of the protein. These chondroitin sulfate side chains are a type of GAG polysaccharide consisting of disaccharide blocks of <italic>N</italic>-acetylgalactosamine and glucuronic acid (<xref ref-type="bibr" rid="B179">Sherman and Back, 2007</xref>). Various CSPGs exist in the ECM throughout the body, but the lectican family of CSPGs is most prominent in PNNs of the CNS. These include aggrecan, neurocan, versican, and brevican, which vary in core protein size and the number of GAG side chains (<xref ref-type="bibr" rid="B210">Yamaguchi, 1999</xref>).</p>
<p>Although lecticans are developmentally regulated, their function in CNS development remains unclear. A developmental upregulation of aggrecan and brevican, which peak in adulthood, was reported in rat brain (<xref ref-type="bibr" rid="B131">Milev et al., 1998</xref>; <xref ref-type="bibr" rid="B26">Brückner et al., 2000</xref>; <xref ref-type="bibr" rid="B157">Popp et al., 2003</xref>). Versican consists of two different alpha and beta isoforms, which are differentially expressed during development. The expression of alpha isoform was low during embryonic development, first and second postnatal weeks, and then increased steadily until around 3.5 months of age (<xref ref-type="bibr" rid="B16">Bignami et al., 1993b</xref>). In contrast, the expression of beta isoform increased 2–3 fold from embryonic day (E) 14 until birth and then decreased in adulthood. Neurocan expression also increased between E14 and postnatal day (P) 3 and then decreased during early-late adolescence and into adulthood (<xref ref-type="bibr" rid="B130">Meyer-Puttlitz et al., 1996</xref>; <xref ref-type="bibr" rid="B132">Miller et al., 1996</xref>; <xref ref-type="bibr" rid="B131">Milev et al., 1998</xref>; <xref ref-type="bibr" rid="B26">Brückner et al., 2000</xref>). Studies of postmortem human tissues also suggest developmental changes in lectican levels in human CNS. For example, high levels of brevican mRNA expression were detected in postmortem human cortex during early development until 8 years of age, and the expression levels were lower in the adult human brain (<xref ref-type="bibr" rid="B68">Gary et al., 2000</xref>). These developmental changes in lectican expression levels suggest that the PNNs themselves may also be developmentally regulated, underlying maturation of circuit function (<xref ref-type="bibr" rid="B101">Köppe et al., 1997</xref>). However, the functional impact of developmental changes in PNN lectican composition is unknown.</p>
</sec>
<sec>
<title>Tenascins and Hyaluronan</title>
<p>Tenascins and hyaluronan are also part of PNN structure. Tenascins are fibrous, matricellular proteins, which bind to the C-terminal domain of lecticans (<xref ref-type="bibr" rid="B4">Aspberg et al., 1997</xref>; <xref ref-type="bibr" rid="B46">Day et al., 2004</xref>). Hyaluronan is an unsulfated GAG that is synthesized at the cell surface by the membrane-bound enzymes called HAS and protrudes through the plasma membrane into the extracellular space (<xref ref-type="bibr" rid="B62">Fraser et al., 1997</xref>). Hyaluronan binds to other ECM molecules via N-terminal hyaluronan binding domains, including lecticans and link proteins such as cartilage link protein, Ctrl1, and brain-derived link proteins Bral1 and Bral2 (<xref ref-type="bibr" rid="B63">Frischknecht and Seidenbecher, 2008</xref>). This complex of hyaluronan with ECM proteins forms the basis for PNN structure. Similar to lecticans, tenascin and hyaluronan are also developmentally regulated. In the mouse cortex, tenascin immunolabeling is first detected around E16 (<xref ref-type="bibr" rid="B178">Sheppard et al., 1991</xref>) and tenascin levels increase after birth until the third postnatal week (<xref ref-type="bibr" rid="B26">Brückner et al., 2000</xref>). By week 4, tenascin expression is reduced to adult levels (<xref ref-type="bibr" rid="B26">Brückner et al., 2000</xref>). Hyaluronan expression precedes the detection of both tenascin and lecticans, and is first observed near the notochord in E11-12 rat embryos (<xref ref-type="bibr" rid="B51">Delpech and Delpech, 1984</xref>; <xref ref-type="bibr" rid="B15">Bignami et al., 1993a</xref>). Hyaluronan is expressed during postnatal development and adulthood but peaks during embryonic development (<xref ref-type="bibr" rid="B15">Bignami et al., 1993a</xref>).</p>
<p>While lecticans, tenascins, and hyaluronan are expressed during embryonic development, the classic net-like structure of PNNs is not typically seen until later during postnatal development. It is unclear how these molecules are assembled to form PNN around neurons, but some studies suggest that both neurons and glial cells are involved in the process (<xref ref-type="bibr" rid="B134">Miyata et al., 2007</xref>; <xref ref-type="bibr" rid="B159">Pyka et al., 2011</xref>). Astrocytes extend their processes into PNNs localized near the synapse (<xref ref-type="bibr" rid="B25">Brückner et al., 1993</xref>; <xref ref-type="bibr" rid="B19">Blümcke et al., 1995</xref>), suggesting a tetrapartite synaptic organization involving ECM, pre/post synaptic sites and astrocytes (<xref ref-type="bibr" rid="B53">Dityatev and Rusakov, 2011</xref>; <xref ref-type="bibr" rid="B183">Smith et al., 2015</xref>) whose synergistic functions remain unexplored.</p>
</sec>
</sec>
<sec>
<title>Parvalbumin Expressing Interneurons, PNNs and MMP-9</title>
<p>In the forebrain, PNNs are often found on PV expressing GABAergic neurons (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). Other cell types, including putative excitatory neurons also contain PNNs but they are less numerous compared to GABAergic-PNN expressing cells (<xref ref-type="bibr" rid="B205">Wegner et al., 2003</xref>). Most studies detecting PNNs in the CNS use fluorescently coupled lectins, such as WFA and <italic>vicia villosa agglutinin</italic>, which bind <italic>N</italic>-acetylgalactosamine on chondroitin sulfate GAG side-chains of CSPGs (<xref ref-type="bibr" rid="B142">Nakagawa et al., 1986</xref>; <xref ref-type="bibr" rid="B102">Kosaka and Heizmann, 1989</xref>; <xref ref-type="bibr" rid="B79">Härtig et al., 1992</xref>). Immunolabeling using antibodies against specific PNN proteins, including aggrecan, tenascin and hyaluronan can also be used to visualize PNNs (<xref ref-type="bibr" rid="B125">Matthews et al., 2002</xref>; <xref ref-type="bibr" rid="B52">Dityatev et al., 2007</xref>; <xref ref-type="bibr" rid="B70">Giamanco et al., 2010</xref>; <xref ref-type="bibr" rid="B209">Yamada and Jinno, 2017</xref>). Studies comparing PNNs detected with lectins or specific antibodies indicate substantial levels of molecular heterogeneity (<xref ref-type="bibr" rid="B125">Matthews et al., 2002</xref>; <xref ref-type="bibr" rid="B92">Irvine and Kwok, 2018</xref>), highlighting the need for better approaches which address PNN heterogeneity (<xref ref-type="bibr" rid="B92">Irvine and Kwok, 2018</xref>). In the following discussion, most studies use lectin based detection of PNNs unless noted otherwise.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Analysis of PV cells enwrapped with PNNs across sensory cortices.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<th align="left" colspan="1" rowspan="1" valign="top">Mouse strain</th>
<th align="left" colspan="1" rowspan="1" valign="top">Methods</th>
<th align="left" colspan="1" rowspan="1" valign="top">PV cells with PNNs (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Visual cortex</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B154"> Pizzo et al., 2016</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: (1) monoclonal mouse α-PV (SWANT, 1:500); (2) polyclonal guinea pig α-PV PNN: biotin-conjugated WFA (Sigma, 1:200)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>All layers</underline> P18: ∼55% P35: ∼55%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B138">Morishita et al., 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: monoclonal rabbit α-PV (SWANT, 1:500) PNN: biotin-conjugated WFA (Vector, 1:400)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>All layers</underline> P50: ∼72%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B110">Lensjø et al., 2017</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: polycolonal rabbit α-PV (SWANT, 1:2000) PNN: biotin-conjugated WFA (Sigma, 1:200)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>All layers</underline> 3–5 months:∼70%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B197">Ueno et al., 2017c</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: monoclonal mouse α-PV (Sigma, 1:1000) PNN: biotin-conjugated WFA (Vector, 1:200)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>All layers</underline> 2–6 months: ∼50-60%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Somatosensory cortex</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B145">Nowicka et al., 2009</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Swiss albino mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: (1) rabbit α-PV (1:1000); (2) monoclonal mouse α-PV (Sigma, 1:1000) PNN: biotin-conjugated WFA (Vector, 1:1000)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<underline>Layer 1–3</underline> P20: &lt;10% P30: ∼30% YA: ∼35% <underline>Layer 4</underline> P10: ∼40% P20: ∼50% P30: ∼50% YA: ∼80% <underline>Layer 5–6</underline> P10: ∼10% P30: ∼35% YA: ∼40%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B196">Ueno et al., 2017b</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: monoclonal mouse α-PV (Sigma, 1:1000) PNN: biotin-conjugated WFA (Vector, 1:200)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>Layer 2-3</underline> P14: ∼70%; P21, 28: ∼50% P56: ∼60% <underline>Layer 4</underline> P14, 21, 28: ∼75% P56: ∼90% <underline>Layer 5-6</underline> P14: ∼75% P21, 28: ∼40-50% P56: ∼60%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B97">Karetko-Sysa et al., 2014</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: polyclonal goat α-PV (Affinity BioReagents, 1:1000) PNN: biotin-conjugated WFA (Vector, 1:1000)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic><sup>∗</sup>Most PV cells colocalized with PNNs in layer 4</italic>
<underline>Layer 4-6</underline> YA: 67%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Auditory cortex</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B24">Brewton et al., 2016</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J CBA/CaJ</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: rabbit α-PV (SWANT, 1:10,000) PNN: FITC-conjugated WFA (Vector, 1:750)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>All layers</underline> C57 YA: 35% CBA YA: 50%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B143">Nguyen et al., 2017</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">CBA/CaJ</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: rabbit α-PV (SWANT, 1:5000) PNN: FITC-conjugated WFA (Vector, 1:500)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>All layers</underline> P30-60: 46%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B206">Wen et al., 2017</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">FVB WT</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: (1) rabbit α-PV (SWANT, 1:5000), (2) mouse α-PV (Sigma, 1:1000) PNN: FITC-conjugated WFA (Vector, 1:500)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>Layer 2/3</underline> P14: ∼1% P21: ∼29% P30: ∼15% <underline>Layer 4</underline> P14: ∼18% P21: ∼38% P30: ∼38%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B197">Ueno et al., 2017c</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">C57BL/6J</td>
<td align="left" colspan="1" rowspan="1" valign="top">PV: monoclonal mouse α-PV (Sigma, 1:1000) PNN: biotin-conjugated WFA (Vector, 1:200)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><underline>All layers</underline> YA: ∼60-70%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>Note that these studies used WFA to stain for PNN. Layer-specific and age-related information are shown if available. P, postnatal day; Young adult (YA) = 3 months</italic>.</attrib>
</table-wrap-foot>
</table-wrap>
<p>Parvalbumin cells are a major class of GABAergic, fast-spiking inhibitory interneurons in the neocortex. Cortical PV cells contribute to synchronous oscillatory activity (<xref ref-type="bibr" rid="B32">Cardin et al., 2009</xref>; <xref ref-type="bibr" rid="B184">Sohal et al., 2009</xref>; <xref ref-type="bibr" rid="B198">Uhlhaas et al., 2009</xref>), particularly in the gamma range (∼30–100 Hz). Like PNNs, PV expression is developmentally regulated and experience-dependent (<xref ref-type="bibr" rid="B88">Hensch, 2005</xref>). In fact, PV and PNN colocalization is correlated with critical period closure and reduced synaptic plasticity, particularly in sensory cortices (<xref ref-type="bibr" rid="B145">Nowicka et al., 2009</xref>; <xref ref-type="bibr" rid="B14">Beurdeley et al., 2012</xref>). A large proportion of PNN-expressing PV cells is found within layer 4 of neocortex (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). Interestingly, developing auditory cortex appears to exhibit fewer PNN and PV expressing cells than visual or somatosensory cortex, but in adult sensory cortices, a majority of PV cells express PNNs as seen with WFA staining. PNNs may regulate PV cell functions (<xref ref-type="bibr" rid="B88">Hensch, 2005</xref>; <xref ref-type="bibr" rid="B30">Cabungcal et al., 2013</xref>; <xref ref-type="bibr" rid="B11">Bernard and Prochiantz, 2016</xref>), as PNN reorganization is shown to result in abnormal CNS development and altered neural excitability (<xref ref-type="bibr" rid="B155">Pizzorusso et al., 2002</xref>; <xref ref-type="bibr" rid="B52">Dityatev et al., 2007</xref>; <xref ref-type="bibr" rid="B114">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="B7">Balmer, 2016</xref>; <xref ref-type="bibr" rid="B110">Lensjø et al., 2017</xref>).</p>
<p>MMP-9 is a zinc-dependent endopeptidase expressed in various cells within the CNS which is capable of cleaving ECM proteins, including collagen and laminin (reviewed in <xref ref-type="bibr" rid="B165">Reinhard et al., 2015</xref>). Peak MMP-9 expression is observed during postnatal development and is reduced during adulthood (<xref ref-type="bibr" rid="B9">Bednarek et al., 2009</xref>; <xref ref-type="bibr" rid="B165">Reinhard et al., 2015</xref>; <xref ref-type="bibr" rid="B206">Wen et al., 2017</xref>). High levels of MMP-9 contribute to proteolytic cleavage of ECM, creating an extracellular environment that is permissive for synaptic plasticity. As aggrecan has been previously identified as an MMP-9 target (<xref ref-type="bibr" rid="B129">Mercuri et al., 2000</xref>; <xref ref-type="bibr" rid="B120">Madsen et al., 2010</xref>; <xref ref-type="bibr" rid="B163">Rankin-Gee et al., 2015</xref>), aggrecan-rich PNNs may be unstable in the presence of MMP-9, leading to abnormal development and neural excitability (<xref ref-type="bibr" rid="B139">Murase et al., 2017</xref>; <xref ref-type="bibr" rid="B206">Wen et al., 2017</xref>). A recent study by Murase and colleagues demonstrated that PV, PNN, and MMP-9 interactions are important for driving adult plasticity (<xref ref-type="bibr" rid="B139">Murase et al., 2017</xref>). In this study, monocular deprivation followed by light exposure in adult mice was associated with reduced WFA-expressing PNNs, lower aggrecan levels, and increased MMP-9 activity, as well as reduced PV cell output, increased firing of regular-spiking cells, and reduced gamma power (<xref ref-type="bibr" rid="B139">Murase et al., 2017</xref>). These findings suggest a link between PNNs, MMP-9 activity and PV activity that shapes normal brain development. Conversely, abnormal interactions may lead to neurological disorders.</p>
</sec>
<sec>
<title>Fragile X Syndrome</title>
<p>Recently, we proposed a hypothesis for increased sensory hyperexcitability in Fragile X syndrome (FXS) through increased MMP-9 levels and abnormal PNN development (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). FXS is a leading genetic cause of autism, occurring in 1 in 4000 males and 1 in 8000 females (<xref ref-type="bibr" rid="B140">Murray et al., 1997</xref>). The most common cause of FXS is an expansion of CGG trinucleotide repeats in 5′ region of the <italic>Fragile X mental retardation 1 (Fmr1)</italic> gene that results in its hypermethylation and inactivation. This leads to loss of Fragile X Mental Retardation protein (FMRP), which is necessary for regulation of protein synthesis (<xref ref-type="bibr" rid="B201">Verkerk et al., 1991</xref>). Individuals with this neurodevelopmental disorder suffer from social and communication deficits, sensory hypersensitivity, and anxiety disorders (<xref ref-type="bibr" rid="B1">Abbeduto and Hagerman, 1997</xref>; <xref ref-type="bibr" rid="B167">Rogers et al., 2001</xref>). Auditory hypersensitivity is common in humans with FXS as measured by increased sound evoked responses, reduced habituation and expansion of brain regions activated by auditory stimuli (<xref ref-type="bibr" rid="B168">Rojas et al., 2001</xref>; <xref ref-type="bibr" rid="B35">Castrén et al., 2003</xref>; <xref ref-type="bibr" rid="B199">Van der Molen et al., 2012</xref>; <xref ref-type="bibr" rid="B57">Ethridge et al., 2016</xref>). These auditory processing deficits may drive social, cognitive and language delays and deficits in FXS (<xref ref-type="bibr" rid="B170">Rotschafer and Razak, 2014</xref>; <xref ref-type="bibr" rid="B180">Sinclair et al., 2017a</xref>,<xref ref-type="bibr" rid="B181">b</xref>).</p>
<p>Auditory hypersensitivity is also evident in <italic>Fmr1</italic> knockout (KO) mice, a mouse model of FXS, which exhibit increased susceptibility to audiogenic seizures (<xref ref-type="bibr" rid="B141">Musumeci et al., 2000</xref>) and abnormal auditory startle (<xref ref-type="bibr" rid="B61">Frankland et al., 2004</xref>). <italic>In vivo</italic> electrophysiological studies demonstrate that neurons in adult <italic>Fmr1</italic> KO mouse auditory cortex (1) are hyperexcitable, exhibiting increased responses per stimulus, (2) show more variable response latencies, and (3) display broader frequency tuning curves (<xref ref-type="bibr" rid="B169">Rotschafer and Razak, 2013</xref>). Recent work using EEG/ERP recordings shows that mature <italic>Fmr1</italic> KO mouse auditory cortex exhibits reduced habituation to repeated sound presentations (<xref ref-type="bibr" rid="B118">Lovelace et al., 2016</xref>). When resting EEG is analyzed for spectral power distribution, <italic>Fmr1</italic> KO mouse cortex shows increased gamma power. There is also enhanced N1 amplitude and reduced gamma phase locking in auditory ERPs (<xref ref-type="bibr" rid="B117">Lovelace et al., 2018</xref>). These phenotypes in the mouse model are remarkably similar to those seen in humans with FXS (<xref ref-type="bibr" rid="B35">Castrén et al., 2003</xref>; <xref ref-type="bibr" rid="B57">Ethridge et al., 2016</xref>; <xref ref-type="bibr" rid="B204">Wang et al., 2017</xref>). These results indicate that there is altered E/I balance in auditory cortex, which may underlie auditory hypersensitivity phenotypes. As PNNs are thought to be critical for maintaining E/I balance by modulating PV neuron activity, we tested the hypothesis that disruption of PNN development may underlie auditory hypersensitivity in FXS.</p>
<p>We found delayed PNN development and increased MMP-9 activity levels in the developing auditory cortex of <italic>Fmr1</italic> KO mice (<xref ref-type="bibr" rid="B206">Wen et al., 2017</xref>), which may lead to impaired PV cell development and reduced inhibition. These phenotypes were mostly observed between P14 and P21 suggesting a window of abnormal development that can be targeted for therapeutic applications. At P14, the responses of single neurons were similar across genotypes, while at P21, <italic>Fmr1</italic> KO neurons show hyper-responsiveness. Genetic reduction of MMP-9 levels in the <italic>Fmr1</italic> KO mice normalized PV/PNN development and also reversed the hyperresponsiveness of auditory cortical neurons. These findings suggest that MMP-9-mediated cleavage of PNNs during development may underlie sensory hypersensitivity in FXS. Reduction of MMP-9 levels with minocycline in humans with FXS (<xref ref-type="bibr" rid="B55">Dziembowska et al., 2013</xref>) contributes to reversal of several FXS phenotypes, including behavioral deficits and enhanced auditory electrocortical activity in adults and/or adolescents with FXS (<xref ref-type="bibr" rid="B152">Paribello et al., 2010</xref>; <xref ref-type="bibr" rid="B107">Leigh et al., 2013</xref>; <xref ref-type="bibr" rid="B176">Schneider et al., 2013</xref>). Minocycline administration in <italic>Fmr1</italic> KO mice prevents abnormal dendritic spine development in the hippocampus, improves anxiety-like behaviors (<xref ref-type="bibr" rid="B17">Bilousova et al., 2009</xref>; <xref ref-type="bibr" rid="B44">Dansie et al., 2013</xref>) and corrects ultrasonic vocalizations (<xref ref-type="bibr" rid="B171">Rotschafer et al., 2012</xref>). Genetic reduction of MMP-9 in <italic>Fmr1</italic> KO mice normalizes PNN formation and prevents the development of neuronal hyperexcitability (<xref ref-type="bibr" rid="B118">Lovelace et al., 2016</xref>; <xref ref-type="bibr" rid="B206">Wen et al., 2017</xref>), emphasizing the therapeutic potential of targeting MMP-9 and PNN in treatment of FXS.</p>
<p>In addition to regulating cortical development, MMP-9 cleavage of PNNs may drive changes in PV expression and/or PV cell functions seen in FXS. The somatosensory cortex of adult FXS mice exhibit delayed PV cell maturation (<xref ref-type="bibr" rid="B144">Nomura et al., 2017</xref>). In developing mice, PV interneurons receive reduced excitatory drive from neighboring pyramidal cells in layer 4 of somatosensory cortex (<xref ref-type="bibr" rid="B71">Gibson et al., 2008</xref>). PV cell maturation is characterized by gradual increases in signaling, including faster firing rates and IPSC kinetics (<xref ref-type="bibr" rid="B105">Lazarus and Huang, 2011</xref>). An orthodenticle homeoprotein, Otx2, may play a role in PV cell maturation and refinement of cortical inhibition. Otx2 expression coincides with both PV and PNN expression in the cortex during critical period plasticity (<xref ref-type="bibr" rid="B188">Sugiyama et al., 2008</xref>). Studies of rodent visual cortex development indicate that Otx2 is localized to GABAergic cells, and is more likely found in PV cells that are enwrapped with PNNs, which contain a specific Otx2 binding site (<xref ref-type="bibr" rid="B14">Beurdeley et al., 2012</xref>). PNNs are necessary for the uptake of Otx2 by PV cells, which promotes PV cell maturation (<xref ref-type="bibr" rid="B14">Beurdeley et al., 2012</xref>). RNA sequencing analysis of PV cells containing Otx2 indicates that Otx2 may be necessary for mitochondrial function, cellular respiration, and redox regulation (<xref ref-type="bibr" rid="B174">Sakai et al., 2017</xref>). These data suggest that PNNs may drive PV cell maturation by directing transcription or translation of specific genes necessary for PV cell function. In FXS, delayed PNN expression around PV cells during development may contribute to abnormal PV cell maturation.</p>
<p>Network excitability in FXS may also result from impaired synaptic scaling at PV cells due to PNN dysfunction. There is evidence for a role of PNNs in mediating synaptic scaling via neuronal activity-regulated pentraxin, also known as <italic>Narp</italic>. <italic>Narp</italic> can interact with the N-terminal domain of AMPA receptors localized extracellularly and facilitate AMPA receptor clustering at both the pre- and post-synaptic cell in response to stimulation (<xref ref-type="bibr" rid="B146">O’Brien et al., 1999</xref>). Studies by <xref ref-type="bibr" rid="B38">Chang et al. (2011)</xref> in developing mouse hippocampus demonstrated that (1) <italic>Narp</italic> was highly expressed at excitatory synapses on PV interneurons, (2) PNN expression facilitated <italic>Narp</italic> expression (and conversely PNN degradation contributed to reduced <italic>Narp</italic> levels), and (3) <italic>Narp</italic> expression at PV interneurons was necessary for increased AMPA receptor-mediated mEPSC amplitude in response to stimulation both <italic>in vitro</italic> and <italic>in vivo</italic>. This suggests that during development, sensory stimuli can activate <italic>Narp</italic> expression which promotes PV interneuron excitation, leading to feed-forward inhibition (<xref ref-type="bibr" rid="B146">O’Brien et al., 1999</xref>; <xref ref-type="bibr" rid="B75">Gu et al., 2013</xref>). In FXS, delayed development of PNNs may contribute to abnormal <italic>Narp</italic> expression, impairing the ability of PV cells to scale cortical networks, resulting in cortical hyperexcitability.</p>
</sec>
<sec>
<title>Schizophrenia</title>
<p>One mechanism that has been proposed to explain some symptoms of schizophrenia is a reduction in GABAergic signaling in specific cortical regions. This is evident from a number of studies characterizing GABAergic cells using antibodies which target GABA-synthesizing enzymes glutamate decarboxylase 65 and 67 (GAD65 and GAD67) in brain tissues from schizophrenia patients. <italic>In situ</italic> hybridization and RT-PCR studies indicate that post-mortem brain tissues from schizophrenia patients exhibit reduced PV and/or GAD67 mRNA, particularly in prefrontal cortex (<xref ref-type="bibr" rid="B2">Akbarian et al., 1995</xref>; <xref ref-type="bibr" rid="B202">Volk et al., 2000</xref>; <xref ref-type="bibr" rid="B85">Hashimoto et al., 2003</xref>, <xref ref-type="bibr" rid="B83">2008a</xref>,<xref ref-type="bibr" rid="B84">b</xref>; <xref ref-type="bibr" rid="B128">Mellios et al., 2009</xref>). Reduced PV and GAD67 protein levels are also seen in both prefrontal and temporal cortex of post-mortem brain tissues (<xref ref-type="bibr" rid="B8">Beasley and Reynolds, 1997</xref>; <xref ref-type="bibr" rid="B43">Curley et al., 2011</xref>; <xref ref-type="bibr" rid="B72">Glausier et al., 2014</xref>). Cortical gamma band oscillations have been attributed to GABAergic cell activity, in particular PV interneurons (<xref ref-type="bibr" rid="B184">Sohal et al., 2009</xref>). Increased gamma-band power was observed in baseline EEG recordings from humans with schizophrenia (<xref ref-type="bibr" rid="B66">Gandal et al., 2012</xref>). In contrast, gamma-band activity that is driven by rapid presentation of auditory stimuli and synchrony or phase-locking of electrocortical activity to these stimuli are reduced in schizophrenic patients compared to healthy controls (<xref ref-type="bibr" rid="B104">Kwon et al., 1999</xref>; <xref ref-type="bibr" rid="B113">Light et al., 2006</xref>). These data suggest altered PV cell function in schizophrenia, but why these cells are susceptible is unclear.</p>
<p>Redox dysregulation has been observed in schizophrenic patients, who have defective antioxidant systems and exhibit increased lipid peroxidation (<xref ref-type="bibr" rid="B54">Do et al., 2000</xref>; <xref ref-type="bibr" rid="B212">Yao et al., 2006</xref>; <xref ref-type="bibr" rid="B60">Flatow et al., 2013</xref>). Genetic analysis of single nucleotide polymorphisms in schizophrenia patients demonstrates mutations in the gene encoding GCL, an enzyme that is important for the production of the cellular antioxidant GSH (<xref ref-type="bibr" rid="B193">Tosic et al., 2006</xref>). PV cells are particularly susceptible to oxidative stress given their fast cellular metabolism and increased mitochondrial function (<xref ref-type="bibr" rid="B82">Hasenstaub et al., 2010</xref>; <xref ref-type="bibr" rid="B95">Kann et al., 2014</xref>; <xref ref-type="bibr" rid="B91">Inan et al., 2016</xref>). Recent studies show that PNNs may protect PV cells from oxidative stress (<xref ref-type="bibr" rid="B30">Cabungcal et al., 2013</xref>; <xref ref-type="bibr" rid="B138">Morishita et al., 2015</xref>), and thus serve as a ‘safety net’ to support the rapid firing properties of PV cells. Cabungcal and colleagues analyzed the levels of oxidative stress in PV cells with and without PNNs in GCL KO mice, a mouse model of schizophrenia, by measuring the levels of 8-hydroxy 2 deoxyguanosine (8-oxo-dG). During development, GCL KO mice had fewer PNN-expressing PV cells in anterior cingulate cortex, and the injection of a dopamine reuptake inhibitor to promote more oxidative stress via buildup of reactive oxygen species contributed to increased 8-oxo-dG signal and PV cell loss. Further analysis indicated that while PV neurons with PNNs were less susceptible to oxidative stress, chABC-mediated degradation of PNNs made PV cells more vulnerable (<xref ref-type="bibr" rid="B30">Cabungcal et al., 2013</xref>). As chABC removes GAG side chains from CSPGs (<xref ref-type="bibr" rid="B20">Bradbury et al., 2002</xref>), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs. Specifically, <italic>in vitro</italic> studies conducted in human neuroblastoma SH-SY5Y cells indicate that chondroitin sulfate application prior to exposure to oxidative-stress inducing agents, such as hydrogen peroxide, can prevent cell death and attenuate the production of reactive oxygen species. Analysis of molecular mechanisms indicates that chondroitin sulfate promotes activation of protein kinase pathways including PKC and PI3K/Akt, and subsequent production of a neuronal antioxidant, heme oxygenase-1 (<xref ref-type="bibr" rid="B31">Cañas et al., 2007</xref>).</p>
<p>Perineuronal net dysfunction in schizophrenia may also drive changes in GABAergic cell function leading to network dysfunction, as normal PNN expression regulates excitability of PV cells (<xref ref-type="bibr" rid="B114">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="B7">Balmer, 2016</xref>). <xref ref-type="bibr" rid="B80">Härtig et al. (1999)</xref> speculated that the large, negatively charged sugar chains, which are enriched in PNNs, might allow for buffering of sodium and potassium ions at synapses. While this mechanism has not been confirmed, chABC-mediated removal of chondroitin sulfate side chains from PNNs reduced spiking of PV cells in adult rats (<xref ref-type="bibr" rid="B7">Balmer, 2016</xref>; <xref ref-type="bibr" rid="B110">Lensjø et al., 2017</xref>) and increased spiking variability (<xref ref-type="bibr" rid="B110">Lensjø et al., 2017</xref>). In addition, brevican conditional knockdown in PV-expressing cells demonstrated that changes in the expression of specific lecticans alter synaptic input and firing frequency in PV cells (<xref ref-type="bibr" rid="B58">Favuzzi et al., 2017</xref>). These findings lend support to the idea that PNN composition plays an important role in regulating PV cell function.</p>
<p>As PNNs regulate GABAergic cell function and oxidative stress levels, cortical abnormalities observed in schizophrenia may be attributed to PNN dysfunction (reviewed in <xref ref-type="bibr" rid="B12">Berretta, 2012</xref>; <xref ref-type="bibr" rid="B13">Berretta et al., 2015</xref>). Indeed, several studies indicate that schizophrenia is associated with the loss of PNNs. Post-mortem brains from patients with schizophrenia exhibit reduced density of WFA-labeled cells (<xref ref-type="bibr" rid="B126">Mauney et al., 2013</xref>) and reduced levels of CSPGs and PV expression in prefrontal cortex (<xref ref-type="bibr" rid="B56">Enwright et al., 2016</xref>). A mouse model of schizophrenia also exhibits reduced PNN levels in prefrontal cortex (<xref ref-type="bibr" rid="B29">Cabungcal et al., 2014</xref>). In this model, schizophrenia-like abnormalities are reported in the adult mouse prefrontal cortex as a result of neonatal lesion of ventral hippocampus. The effects of dysregulated dopamine signaling on prefrontal cortex oscillatory activity, which are suggested to drive schizophrenia phenotypes, can be also regulated by PNNs. For example, network oscillatory activity that was increased by drug-induced changes in dopaminergic signaling in mouse prefrontal cortex was further enhanced following chABC-mediated degradation of PNNs (<xref ref-type="bibr" rid="B186">Steullet et al., 2014</xref>).</p>
<p>Recent studies have hinted at the potential role of MMP-9 in the manifestation of schizophrenia phenotypes. A functional polymorphism of the MMP-9 gene was discovered in human schizophrenia patients (<xref ref-type="bibr" rid="B173">Rybakowski et al., 2009</xref>; <xref ref-type="bibr" rid="B111">Lepeta et al., 2017</xref>). Additionally, <xref ref-type="bibr" rid="B211">Yamamori et al. (2013)</xref> showed elevated MMP-9 levels in the plasma of schizophrenic patients. Various clinical trials have been conducted using minocycline alone or as an adjunct to risperidone in patients with schizophrenia and have demonstrated overall improvement in negative symptoms and executive functioning (<xref ref-type="bibr" rid="B133">Miyaoka et al., 2008</xref>; <xref ref-type="bibr" rid="B112">Levkovitz et al., 2010</xref>; <xref ref-type="bibr" rid="B98">Khodaie-Ardakani et al., 2014</xref>). Beside its antibiotic activity, minocycline can reduce plasma levels of MMP-9 (<xref ref-type="bibr" rid="B55">Dziembowska et al., 2013</xref>) and inhibit MMP-9 activity (<xref ref-type="bibr" rid="B106">Lee et al., 2006</xref>), suggesting a possible role of MMP-9 inhibition in the beneficial effects of minocycline in schizophrenia. Clearly additional studies are needed to test whether elevated MMP-9 levels do indeed drive PNN changes observed in prefrontal cortex of schizophrenia mouse models and how it relates to the human condition. Future studies can help to determine whether ECM abnormalities underlie the changes in GABAergic signaling and redox dysregulation associated with schizophrenia.</p>
</sec>
<sec>
<title>Seizures and Epilepsy</title>
<p>Epilepsy occurs unpredictably and affects people of all ages, although onset commonly occurs in childhood (<xref ref-type="bibr" rid="B86">Hauser, 1992</xref>). It is idiopathic and can include generalized seizures, which involve epileptiform activity emanating from the entire cortex, as well as focal or partial seizures, which result from epileptiform activity from a single part of the cortex (<xref ref-type="bibr" rid="B86">Hauser, 1992</xref>). The molecular mechanisms underlying seizure onset include impaired PV cell functions. Analysis of post-mortem human brain tissues demonstrated reduced PV cell density and immunoreactivity at epileptic foci in the hippocampus and neocortex (<xref ref-type="bibr" rid="B182">Sloviter et al., 1991</xref>; <xref ref-type="bibr" rid="B59">Ferrer et al., 1994</xref>; <xref ref-type="bibr" rid="B3">Andrioli et al., 2007</xref>). Genomic sequencing data indicate that a number of mutations in the <italic>Scn1a</italic> gene contribute to a spectrum of different epileptic disorders affecting children, including <italic>de novo</italic> (<xref ref-type="bibr" rid="B42">Claes et al., 2001</xref>; <xref ref-type="bibr" rid="B64">Fujiwara et al., 2003</xref>) as well as missense, frame-shift, and nonsense mutations (<xref ref-type="bibr" rid="B64">Fujiwara et al., 2003</xref>). <italic>Scn1a</italic> is a gene that encodes Nav1.1, a sodium channel necessary for PV cell firing (<xref ref-type="bibr" rid="B147">Ogiwara et al., 2007</xref>; <xref ref-type="bibr" rid="B87">Hedrich et al., 2014</xref>). Recent studies demonstrate that reduced PV cell spike output may contribute to seizures in mice with genetic knock-in of mutated human <italic>Scn1a</italic>, which results in subtle changes in Nav1.1 functionality (<xref ref-type="bibr" rid="B147">Ogiwara et al., 2007</xref>; <xref ref-type="bibr" rid="B87">Hedrich et al., 2014</xref>). Several rodent models of epilepsy, which use drugs to induce seizures, also shed some light on the role of PV cells. For example, PV KO mice are more likely to experience status epilepticus compared to controls following increased doses of pentylenetetrazol (PTZ), a GABA<sub>A</sub> receptor blocker (<xref ref-type="bibr" rid="B177">Schwaller et al., 2004</xref>).</p>
<p>As PNNs regulate PV cell activity (<xref ref-type="bibr" rid="B7">Balmer, 2016</xref>; <xref ref-type="bibr" rid="B110">Lensjø et al., 2017</xref>) and protect PV cells from oxidative stress (<xref ref-type="bibr" rid="B30">Cabungcal et al., 2013</xref>), PNNs can be potentially targeted to control seizures. Recent work has reported changes in PNN integrity in epilepsy. Drug-induced seizures led to increased expression of aggrecan cleavage products around PV cells and reduced expression of PNN components in rodent hippocampus, including Ctrl1 and hyaluronan synthase 3, both of which help to stabilize PNNs (<xref ref-type="bibr" rid="B127">McRae and Porter, 2012</xref>; <xref ref-type="bibr" rid="B163">Rankin-Gee et al., 2015</xref>). Drug-induced seizures increased unbound CSPG levels and decreased the levels of CSPGs associated with PNNs around PV cells, which were detected with WFA in cerebral cortex (<xref ref-type="bibr" rid="B213">Yutsudo and Kitagawa, 2015</xref>). In rodent piriform cortex, kindling-induced seizures caused PNN degradation and increased GABAergic synapses, contributing to the rewiring of cortical networks (<xref ref-type="bibr" rid="B156">Pollock et al., 2014</xref>). Moreover, PNN breakdown induced by seizures was at least partially facilitated by increased enzymatic activity of MMPs (<xref ref-type="bibr" rid="B99">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="B163">Rankin-Gee et al., 2015</xref>), and seizure susceptibility was reduced in MMP-9 KO mice (<xref ref-type="bibr" rid="B207">Wilczynski et al., 2008</xref>). This suggests that PNN breakdown via MMP-9 following seizure induction contributes to network rewiring, leading to pathological hyperexcitability. Future studies should explore this PNN loss-hyperexcitability connection further and determine whether there would be therapeutic benefit to MMP inhibition and PNN restoration in epilepsy.</p>
</sec>
<sec>
<title>CNS Injury and Stroke</title>
<p>In CNS injury and stroke, re-establishing neuronal plasticity appears to be key for re-innervation and recovery. A full summary of this literature is outside the scope this review, so only a few exemplars are mentioned to make the point that understanding the contributions of PNN and other ECM molecules may be critical in developing treatments, because the CSPGs present in PNNs appear to inhibit axonal growth (<xref ref-type="bibr" rid="B103">Kwok et al., 2011</xref>). In rat spinal cord injury models, increased concentrations of CSPGs and PNN expression were found at injury sites and surrounding secondary dorsal column relay neurons (<xref ref-type="bibr" rid="B123">Massey et al., 2008</xref>). When sensory axons were transplanted into adult rats with dorsal column lesions, neurons were able to sprout and extend their processes to additional denervated areas, but failed to penetrate the original lesion sites, which lead to denervation of upstream pathways and inactivation of parts of somatosensory cortex (<xref ref-type="bibr" rid="B45">Davies et al., 1999</xref>; <xref ref-type="bibr" rid="B94">Kaas et al., 2008</xref>). CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury. This not only resulted in an increase in terminals from initially injured afferents, but also contributed to expanded receptive fields of uninjured primary afferents (<xref ref-type="bibr" rid="B20">Bradbury et al., 2002</xref>; <xref ref-type="bibr" rid="B124">Massey et al., 2006</xref>).</p>
<p>Studies in stroke models indicate that injury onset leads to two processes. On the one hand, focal cortical stroke in rats contributes to upregulation of a number of CSPG-encoding genes particularly near the infarct and glial scar. RT-PCR analysis of the affected tissue indicated upregulation of neurocan, which peaked on the third day following middle cerebral artery occlusion, as well as versican and brevican, both of which peaked by day 28 (<xref ref-type="bibr" rid="B33">Carmichael et al., 2005</xref>). In contrast, in cortical areas surrounding the infarct and outside of the glial scar, WFA-expressing PNNs are completely degraded by day 7, and CSPG immunoreactivity is down regulated although they remain detectable up to 14 days post-injury (<xref ref-type="bibr" rid="B89">Hobohm et al., 2005</xref>). Similar degradation of WFA-expressing PNNs in the neocortex has also been observed following thromboembolic middle cerebral artery occlusion in rats, permanent middle artery occlusion in mice, and focal cerebral ischemia in sheep (<xref ref-type="bibr" rid="B81">Härtig et al., 2017</xref>). Interestingly, reduced PV-immunoreactivity and PV cell function have also been observed following stroke and this decrease in inhibitory cell function may underlie epilepsy-like activity following stroke (<xref ref-type="bibr" rid="B89">Hobohm et al., 2005</xref>; <xref ref-type="bibr" rid="B208">Xie et al., 2014</xref>). As CSPGs inhibit growth, these findings indicate that spinal cord injury, stroke and/or traumatic brain injury may contribute to ECM reorganization, allowing neuronal growth and plasticity in areas free from damage and inhibiting growth where injury-induced cellular damage is more severe (<xref ref-type="bibr" rid="B89">Hobohm et al., 2005</xref>; <xref ref-type="bibr" rid="B77">Harris et al., 2010</xref>). MMP-9 may be responsible for this ECM reorganization as a number of studies have demonstrated increased MMP-9 levels following CNS injury and stroke in humans as well as animal models (<xref ref-type="bibr" rid="B214">Zhang et al., 2011</xref>; <xref ref-type="bibr" rid="B39">Chaturvedi and Kaczmarek, 2014</xref>; <xref ref-type="bibr" rid="B115">Liu et al., 2014</xref>).</p>
</sec>
<sec>
<title>Alzheimer’S Disease</title>
<p>Alzheimer’s disease is associated with memory impairment, which may be attributed to intracellular buildup of neurofibrillary tangles and the accumulation of extracellular beta-amyloid plaques in hippocampus and cortex. This may lead to hippocampal and cortical hyperexcitability as well as increased seizure susceptibility in both AD humans and rodent models (<xref ref-type="bibr" rid="B150">Palop et al., 2007</xref>; <xref ref-type="bibr" rid="B166">Roberson et al., 2011</xref>). Post-mortem brains of AD patients exhibit reduced expression of PNNs, particularly in the hippocampus (<xref ref-type="bibr" rid="B6">Baig et al., 2005</xref>; <xref ref-type="bibr" rid="B109">Lendvai et al., 2013</xref>). Neurons that exhibit buildup of tau protein and neurofibrillary tangles are more likely to lack PNNs (<xref ref-type="bibr" rid="B27">Brückner et al., 1999</xref>; <xref ref-type="bibr" rid="B136">Morawski et al., 2010</xref>). Direct support for the neuroprotective effects of PNNs from AD-related pathology was demonstrated in rodent cortical neurons <italic>in vitro.</italic> These experiments showed that PNN-ensheathed cells were more resistant to cell death when neurons were incubated with exogenous monomeric Aβ1-42 peptide for 48 h. More cells died when pretreated with chABC (<xref ref-type="bibr" rid="B134">Miyata et al., 2007</xref>). The neuroprotective abilities of PNNs may stem from their ability to act as a barrier for oxidative stress-inducing molecules, such as metal ions. The molecules can react with free radicals generated by cellular metabolism to generate even more free radicals, resulting in lipid peroxidation, oxidative stress, and cell death (<xref ref-type="bibr" rid="B187">Stohs and Bagchi, 1995</xref>). Indeed, cortical cells expressing PNNs exhibited accumulation of iron in post-fixed brain tissues obtained from both AD and normally aged controls (<xref ref-type="bibr" rid="B164">Reinart et al., 2003</xref>). Accumulation of lipofuscin, a byproduct of iron-catalyzed oxidative stress, was also observed in cells without PNN (<xref ref-type="bibr" rid="B137">Morawski et al., 2004</xref>). These results indicate that cells without PNNs are more susceptible to cell death (<xref ref-type="bibr" rid="B137">Morawski et al., 2004</xref>). Similar results have been obtained in AD rodent models, which rely on bilateral or unilateral microinjection of iron chloride into mouse cortex to mimic AD-related oxidative stress. While iron-induced oxidative stress resulted in apoptotic cell death in cells without PNNs, neurons with PNNs were more likely to survive (<xref ref-type="bibr" rid="B190">Suttkus et al., 2012</xref>, <xref ref-type="bibr" rid="B191">2014</xref>). Genetic reduction of aggrecan, which has the highest number of CS-side chains and presumably the largest negative charge, resulted in reduced neuroprotective effects (<xref ref-type="bibr" rid="B191">Suttkus et al., 2014</xref>). These results lend further support to the idea that the CS-side chains of PNNs mediate its neuroprotective effects.</p>
<p>Perineuronal net loss in AD may contribute to altered E/I balance (<xref ref-type="bibr" rid="B150">Palop et al., 2007</xref>; <xref ref-type="bibr" rid="B189">Sun et al., 2009</xref>), synaptic loss (<xref ref-type="bibr" rid="B175">Scheibel and Tomiyasu, 1978</xref>; <xref ref-type="bibr" rid="B172">Ruiter and Uyling, 1987</xref>; <xref ref-type="bibr" rid="B90">Hoover et al., 2010</xref>) and increased susceptibility to oxidative stress (<xref ref-type="bibr" rid="B50">Deibel et al., 1996</xref>; <xref ref-type="bibr" rid="B200">Varadarajan et al., 2000</xref>; <xref ref-type="bibr" rid="B121">Manczak et al., 2006</xref>; <xref ref-type="bibr" rid="B47">De Felice et al., 2007</xref>). Interestingly, some studies suggest that MMP-9 may be a key molecular target in treating AD, as MMP-9 is capable of cleaving Aβ <italic>in vitro</italic> (<xref ref-type="bibr" rid="B5">Backstrom et al., 1996</xref>), and plasma levels of MMP-9 are elevated in AD patients (<xref ref-type="bibr" rid="B5">Backstrom et al., 1996</xref>; <xref ref-type="bibr" rid="B116">Lorenzl et al., 2003</xref>). As MMP-9 is also involved in PNN maintenance, elevated MMP-9 levels may contribute to both PNN degradation and altered levels of Aβ in AD.</p>
</sec>
<sec>
<title>Hearing Loss and Central Auditory Processing</title>
<p>Recent studies suggest that loss of PNNs around PV cells occurs following noise-induced and age-related hearing loss. Overexposure to loud sounds can cause hair cell damage (<xref ref-type="bibr" rid="B158">Puel et al., 1998</xref>), hearing loss and reduced afferent input in the auditory system (<xref ref-type="bibr" rid="B192">Syka, 2002</xref>). Noise-induced hearing loss leads to increased excitability (gain) in the central auditory system, but the cellular mechanisms are not clear. PNNs are impaired following noise induced hearing loss, even within 1 day after noise exposure. Specifically, PNN intensity is reduced in layers 1–4 of auditory cortex of adult CBA mice 1, 10, and 30 days post-noise exposure. In layers 5–6, PNN intensity decreases 10 days post-noise exposure (<xref ref-type="bibr" rid="B143">Nguyen et al., 2017</xref>). Reduced PNN intensity may be a result of increased cleavage or degradation of various PNN components, such as CSPGs, hyaluronan, or link proteins. In brainstem auditory nuclei of mice, genetic loss of brevican contributes to loss of brevican-expressing PNNs as well as reduced sound-evoked firing rates and increased neuronal response thresholds (<xref ref-type="bibr" rid="B18">Blosa et al., 2015</xref>). chABC-mediated degradation of PNNs around PV cells in brainstem and central auditory neurons has similar effects, resulting in reduced PV cell excitability and gain (<xref ref-type="bibr" rid="B7">Balmer, 2016</xref>). These results indicate that PNNs may be necessary for neuronal excitability throughout the auditory pathway. Understanding the auditory system’s ability to control excitability as a result of exposure to traumatic sounds and the potential role of PNNs in regulating this process may help to characterize molecular targets in treatment of noise induced hearing loss and tinnitus.</p>
<p>Age-related hearing loss, also known as presbycusis, is associated with difficulty interpreting speech and slower auditory processing (<xref ref-type="bibr" rid="B69">Gates and Mills, 2005</xref>) which may lead to social isolation and cognitive decline. Hearing aids amplify sounds, but may not improve speech processing, suggesting central auditory system changes. Neuronal response properties susceptible to presbycusis include frequency selectivity, spontaneous activity levels and spectrotemporal selectivity (<xref ref-type="bibr" rid="B194">Trujillo and Razak, 2013</xref>). GABAergic signaling is involved in shaping these properties, with fast-spiking PV cells shaping both spectral and temporal selectivity (<xref ref-type="bibr" rid="B135">Moore and Wehr, 2012</xref>). Indeed, several studies have demonstrated reduced GABAergic signaling in the aged auditory system of rodents and humans (<xref ref-type="bibr" rid="B34">Caspary et al., 1990</xref>; <xref ref-type="bibr" rid="B149">Ouda et al., 2008</xref>; <xref ref-type="bibr" rid="B122">Martin del Campo et al., 2012</xref>; <xref ref-type="bibr" rid="B67">Gao et al., 2015</xref>).</p>
<p>Perineuronal nets may play a major role in PV neuron susceptibility and altered cortical processing in presbycusis. The number of PNN expressing cells is reduced in aging mouse auditory cortex with a particular impact on PV/PNN co-localized cells (<xref ref-type="bibr" rid="B24">Brewton et al., 2016</xref>). As PNNs protect PV cells from oxidative stress, these data indicate that PNN downregulation with age may make PV cells more susceptible to cell death. Altered PNN formation may contribute to abnormal GABAergic signaling and impaired temporal processing with age, leading to deficits in speech comprehension. Additional studies are required to identify the specific components of PNNs that are altered in noise- and age-related hearing loss.</p>
</sec>
<sec>
<title>Conclusion and Future Studies</title>
<p>Accumulating evidence suggests that PNN loss is associated with a number of neurological disorders. PNNs are also implicated in experience-dependent plasticity during development. In fact, activity-dependent synaptogenesis and the development of stable neuronal networks may be a result of normal PNN interactions with inhibitory interneurons, in particular fast spiking PV cells. Despite the evidence for developmental and pathological changes in PNNs, their precise role in network function and development is not known. Additional studies are needed that compare intrinsic and synaptic properties of the same cell types with and without PNNs. While the use of chABC has been useful in addressing PNN function, this enzyme likely has broader effects. Additional methods such as genetic removal of specific PNN components are needed.</p>
<p>Considering the prominent role of PNNs in many processes within the CNS, more focus should be placed on characterizing the mechanisms of PNN regulation in the healthy and diseased brain. Some of the work reviewed here indicates that PNNs are necessary for PV cell function, yet in several brain areas not all PV cells are ensheathed by PNNs as labeled with WFA (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). PNNs are heterogeneous structures (<xref ref-type="bibr" rid="B196">Ueno et al., 2017b</xref>; <xref ref-type="bibr" rid="B209">Yamada and Jinno, 2017</xref>; <xref ref-type="bibr" rid="B92">Irvine and Kwok, 2018</xref>), and PNN composition may be brain region- and developmental age-specific. For instance, in the rodent hippocampus, aggrecan-expressing PNNs overlap with WFA labeling in stratum oriens, but stratum pyramidale exhibits aggrecan-rich PNNs, which are not WFA-positive (<xref ref-type="bibr" rid="B209">Yamada and Jinno, 2017</xref>). PNNs containing aggrecan and brevican do not always overlap in mouse somatosensory cortex (<xref ref-type="bibr" rid="B65">Galtrey et al., 2008</xref>; <xref ref-type="bibr" rid="B196">Ueno et al., 2017b</xref>). Tenascin-R expressing PNNs are not observed in rodent PFC, but are prominent in other cortical areas (<xref ref-type="bibr" rid="B195">Ueno et al., 2017a</xref>). These findings suggest that future work characterizing other PNN components such as hyaluronan (<xref ref-type="bibr" rid="B148">Oohashi et al., 2015</xref>) will be helpful in understanding PNN development and re-organization in health and disease. New models that allow for the examination of PNN formation and restructuring in the living brain will contribute to a better understanding of its role in circuit function. Genetic approaches to visualize and disassemble PNNs will also be very important moving forward.</p>
<p>Mechanisms of PNN loss and restructuring in disease are still not clear. One of the ECM modifying enzymes, MMP-9, has been hypothesized to play a role in pathophysiology of schizophrenia, AD and FXS. As MMP-9 is capable of cleaving ECM, elevated MMP-9 levels can drive PNN loss and re-organization. As there is evidence for abnormal MMP-9 regulation in FXS, schizophrenia and AD as well as altered PNNs in presbycusis and acoustic trauma models, studies of how MMP-9 is involved in PNN regulation are crucial for the development and validation of future therapeutics. Recent studies indicate that minocycline administration may reverse both schizophrenia and FXS phenotypes, perhaps due to its ability to lower MMP-9 levels or activity (<xref ref-type="bibr" rid="B55">Dziembowska et al., 2013</xref>). As MMP-9 cleaves PNN components, perhaps the use of more specific MMP-9 inhibitors may yield higher efficacy in treatment of these and other neurological disorders.</p>
<p>While we have focused on the potential role of MMP-9 in regulating PNNs and neural excitability in disease pathology, the ADAMTs family of aggrecanases may also cause PNN cleavage and reorganization. Indeed, several ADAMTs are upregulated following spinal cord injury, stroke, and epilepsy (<xref ref-type="bibr" rid="B108">Lemarchant et al., 2013</xref>; <xref ref-type="bibr" rid="B100">Kim et al., 2016</xref>). In addition, a number of molecules can regulate MMP-9 activity itself, including tissue inhibitors of MMPs, known as TIMPs, which form 1:1 complexes with MMPs in order to inhibit MMP activity (<xref ref-type="bibr" rid="B74">Gomis-Rüth et al., 1997</xref>; <xref ref-type="bibr" rid="B23">Brew and Nagase, 2010</xref>). TIMP levels are increased in postmortem brains of AD patients (<xref ref-type="bibr" rid="B153">Peress et al., 1995</xref>), and may be indicators for risk of stroke mortality (<xref ref-type="bibr" rid="B76">Hansson et al., 2011</xref>). Schizophrenia is associated with higher MMP-9/TIMP1 ratios compared to healthy controls (<xref ref-type="bibr" rid="B161">Rahimi et al., 2017</xref>). Future work characterizing the expression of other MMPs in disease pathology may also be useful as a number of MMPs can directly or indirectly activate MMP-9, including MMP-7, MMP-3, and MMP-14. Quantitative PCR analysis indicates that transcripts from MMP-9, 3, 7, and 14 are upregulated in rodent models of spinal cord injury (<xref ref-type="bibr" rid="B214">Zhang et al., 2011</xref>). Understanding how other MMP-9 and PNN modifying enzymes are regulated may contribute to the development of new targets in treating neurological disorders.</p>
<p>As PNNs may play a major role in disease pathology, the development of therapeutic interventions, which target these structures, may be key in restoring neuronal excitability and cortical function. For instance, recent findings in rodent stroke models indicate that rats housed in enriched environments following ischemic damage exhibited faster neurological recovery compared to rats placed in standard housing (<xref ref-type="bibr" rid="B119">Madinier et al., 2014</xref>; <xref ref-type="bibr" rid="B160">Quattromani et al., 2018</xref>). Quatrromani and colleagues suggest that this phenomenon may be attributed to sensorimotor stimulation which results in increased protease activity and reduced expression of PNNs. As the absence of PNNs is associated with increased plasticity (<xref ref-type="bibr" rid="B155">Pizzorusso et al., 2002</xref>; <xref ref-type="bibr" rid="B145">Nowicka et al., 2009</xref>), this may allow for axonal outgrowth and synaptogenesis, particularly in surviving cortical areas, which exhibit reduced CSPG and PNN expression and are therefore growth permissive (2014). These findings suggest that comparable human treatments, which target PNNs specifically, might involve non-invasive brain stimulation or combination brain stimulation/protease inhibitor treatments. While brain stimulation techniques are already currently utilized to treat neurological disorders (<xref ref-type="bibr" rid="B41">Cirillo et al., 2017</xref>), understanding how PNNs are modified following stimulation in rodents would lend support for use of this treatment paradigm, particularly in disorders involving abnormal PNNs.</p>
<p>While we do not emphasize inflammatory response pathways in the present review, these may be crucial in understanding MMP-9 dysregulation in CNS disorders as there is evidence for neuro-inflammation in injury models, AD, epilepsy, and schizophrenia (<xref ref-type="bibr" rid="B151">Papa et al., 2014</xref>). Cirillo and colleagues suggest that following insult, reactive gliosis triggers activation of MMPs and maladaptive plasticity, perhaps due to increased degradation of neurotrophins such as NGF (<xref ref-type="bibr" rid="B49">De Luca et al., 2016</xref>; <xref ref-type="bibr" rid="B40">Cirillo et al., 2016</xref>). Neurotrophins are necessary for neuronal growth and plasticity, and increased MMP-9 activity has been shown to degrade mature NGF (<xref ref-type="bibr" rid="B28">Bruno and Cuello, 2006</xref>). Moreover, recent work in peripheral nerve injury models indicates that co-treatment with MMP-9 inhibitors and NGF peptide following insult can restore synaptic homeostasis, i.e., normalize glutamate/GABA ratio and expression of glial amino acid transporters (<xref ref-type="bibr" rid="B49">De Luca et al., 2016</xref>; <xref ref-type="bibr" rid="B40">Cirillo et al., 2016</xref>). Unlike FXS, where MMP-9 upregulation can likely be attributed to loss of the <italic>Fmr1</italic> gene (<xref ref-type="bibr" rid="B93">Janusz et al., 2013</xref>), these findings provide important mechanistic insight for how MMP-9 dysregulation might arise in other CNS diseases. Whether NGF downregulation alters PNN expression remains to be studied. However, if NGF does play a role, this has important implications for the development of new PNN-targeting therapies.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>TW reviewed the literature and wrote the manuscript. IE, DB, and KR were involved in writing and editing the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer GC and handling Editor declared their shared affiliation.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> Research on PV/PNN in FXS was funded by NIH grant U54 HD082008 to IE, KR, and DB.</p>
</fn>
</fn-group>
<ack>
<p>We thank members of IE, KR, and DB labs for valuable inputs on ideas presented in this review.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbeduto</surname><given-names>L.</given-names></name><name><surname>Hagerman</surname><given-names>R.</given-names></name></person-group> (<year>1997</year>). <article-title>Language and communication in fragile X syndrome.</article-title>
<source/><italic>Dev. Disabil. Res. Rev.</italic>
<volume>3</volume>
<fpage>313</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1098-2779(1997)3:4&lt;313::AID-MRDD6&gt;3.0.CO;2-O</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbarian</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J. J.</given-names></name><name><surname>Potkin</surname><given-names>S. G.</given-names></name><name><surname>Hagman</surname><given-names>J. O.</given-names></name><name><surname>Tafazzoli</surname><given-names>A.</given-names></name><name><surname>Bunney</surname><given-names>W. E.</given-names><suffix>Jr.</suffix></name><etal></etal></person-group> (<year>1995</year>). <article-title>Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>52</volume>
<fpage>258</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1995.03950160008002</pub-id>
<pub-id pub-id-type="pmid">7702443</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrioli</surname><given-names>A.</given-names></name><name><surname>Alonso-Nanclares</surname><given-names>L.</given-names></name><name><surname>Arellano</surname><given-names>J. I.</given-names></name><name><surname>DeFelipe</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Quantitative analysis of parvalbumin-immunoreactive cells in the human epileptic hippocampus.</article-title>
<source/><italic>Neuroscience.</italic>
<volume>149</volume>
<fpage>131</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.07.029</pub-id>
<pub-id pub-id-type="pmid">17850980</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aspberg</surname><given-names>A.</given-names></name><name><surname>Miura</surname><given-names>R.</given-names></name><name><surname>Bourdoulous</surname><given-names>S.</given-names></name><name><surname>Shimonaka</surname><given-names>M.</given-names></name><name><surname>Heinegård</surname><given-names>D.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein– protein interactions independent of carbohydrate moiety.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>94</volume>
<fpage>10116</fpage>–<lpage>10121</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.19.10116</pub-id>
<pub-id pub-id-type="pmid">9294172</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Backstrom</surname><given-names>J. R.</given-names></name><name><surname>Lim</surname><given-names>G. P.</given-names></name><name><surname>Cullen</surname><given-names>M. J.</given-names></name><name><surname>Tökés</surname><given-names>Z. A.</given-names></name></person-group> (<year>1996</year>). <article-title>Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1–40).</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>16</volume>
<fpage>7910</fpage>–<lpage>7919</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-24-07910.1996</pub-id>
<pub-id pub-id-type="pmid">8987819</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baig</surname><given-names>S.</given-names></name><name><surname>Wilcock</surname><given-names>G. K.</given-names></name><name><surname>Love</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s Disease.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>110</volume>
<fpage>393</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-005-1060-2</pub-id>
<pub-id pub-id-type="pmid">16133543</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balmer</surname><given-names>T.S.</given-names></name></person-group> (<year>2016</year>). <article-title>Perineuronal nets enhance the excitability of fast-spiking neurons.</article-title>
<source/><italic>eNeuro</italic>
<volume>3</volume> ENEURO.0112-16.2016. <pub-id pub-id-type="doi">10.1523/ENEURO.0112-16.2016</pub-id>
<pub-id pub-id-type="pmid">27570824</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beasley</surname><given-names>C. L.</given-names></name><name><surname>Reynolds</surname><given-names>G. P.</given-names></name></person-group> (<year>1997</year>). <article-title>Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>24</volume>
<fpage>349</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/S0920-9964(96)00122-3</pub-id>
<pub-id pub-id-type="pmid">9134596</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bednarek</surname><given-names>N.</given-names></name><name><surname>Clément</surname><given-names>Y.</given-names></name><name><surname>Lelièvre</surname><given-names>V.</given-names></name><name><surname>Olivier</surname><given-names>P.</given-names></name><name><surname>Loron</surname><given-names>G.</given-names></name><name><surname>Garnotel</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Ontogeny of MMPs and TIMPs in the murine neocortex.</article-title>
<source/><italic>Pediatr. Res.</italic>
<volume>65</volume>
<fpage>296</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1203/PDR.0b013e3181973aee</pub-id>
<pub-id pub-id-type="pmid">19092727</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berardi</surname><given-names>N.</given-names></name><name><surname>Pizzorusso</surname><given-names>T.</given-names></name><name><surname>Maffei</surname><given-names>L.</given-names></name></person-group> (<year>2004</year>). <article-title>Extracellular matrix and visual cortical plasticity: freeing the synapse.</article-title>
<source/><italic>Neuron</italic>
<volume>44</volume>
<fpage>905</fpage>–<lpage>908</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.12.008</pub-id>
<pub-id pub-id-type="pmid">15603733</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernard</surname><given-names>C.</given-names></name><name><surname>Prochiantz</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Otx2-PNN interaction to regulate cortical plasticity.</article-title>
<source/><italic>Neural Plast.</italic>
<volume>2016</volume>:<issue>7931693</issue>. <pub-id pub-id-type="doi">10.1155/2016/7931693</pub-id>
<pub-id pub-id-type="pmid">26881132</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berretta</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Extracellular matrix abnormalities in schizophrenia.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>62</volume>
<fpage>1584</fpage>–<lpage>1597</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.08.010</pub-id>
<pub-id pub-id-type="pmid">21856318</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berretta</surname><given-names>S.</given-names></name><name><surname>Pantazopoulos</surname><given-names>H.</given-names></name><name><surname>Markota</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>C.</given-names></name><name><surname>Batzianouli</surname><given-names>E. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>167</volume>
<fpage>18</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2014.12.040</pub-id>
<pub-id pub-id-type="pmid">25601362</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beurdeley</surname><given-names>M.</given-names></name><name><surname>Spatazza</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>H. H.</given-names></name><name><surname>Sugiyama</surname><given-names>S.</given-names></name><name><surname>Bernard</surname><given-names>C.</given-names></name><name><surname>Di Nardo</surname><given-names>A. A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Otx2 binding to perineuronal nets persistently regulates plasticity in the mature visual cortex.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>9429</fpage>–<lpage>9437</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0394-12.2012</pub-id>
<pub-id pub-id-type="pmid">22764251</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bignami</surname><given-names>A.</given-names></name><name><surname>Hosley</surname><given-names>M.</given-names></name><name><surname>Dahl</surname><given-names>D.</given-names></name></person-group> (<year>1993a</year>). <article-title>Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix.</article-title>
<source/><italic>Anat. Embryol.</italic>
<volume>188</volume>
<fpage>419</fpage>–<lpage>433</lpage>.<pub-id pub-id-type="pmid">7508695</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bignami</surname><given-names>A.</given-names></name><name><surname>Perides</surname><given-names>G.</given-names></name><name><surname>Rahemtulla</surname><given-names>F.</given-names></name></person-group> (<year>1993b</year>). <article-title>Versican, a hyaluronate-binding proteoglycan of embryonal precartilaginous mesenchyma, is mainly expressed postnatally in rat brain.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>34</volume>
<fpage>97</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="pmid">7678658</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilousova</surname><given-names>T. V.</given-names></name><name><surname>Dansie</surname><given-names>L.</given-names></name><name><surname>Ngo</surname><given-names>M.</given-names></name><name><surname>Aye</surname><given-names>J.</given-names></name><name><surname>Charles</surname><given-names>J. R.</given-names></name><name><surname>Ethell</surname><given-names>D. W.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>46</volume>
<fpage>94</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2008.061796</pub-id>
<pub-id pub-id-type="pmid">18835858</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blosa</surname><given-names>M.</given-names></name><name><surname>Sonntag</surname><given-names>M.</given-names></name><name><surname>Jäger</surname><given-names>C.</given-names></name><name><surname>Weigel</surname><given-names>S.</given-names></name><name><surname>Seeger</surname><given-names>J.</given-names></name><name><surname>Frischknecht</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The extracellular matrix molecule brevican is an integral component of the machinery mediating fast synaptic transmission at the calyx of Held.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>593</volume>
<fpage>4341</fpage>–<lpage>4360</lpage>. <pub-id pub-id-type="doi">10.1113/JP270849</pub-id>
<pub-id pub-id-type="pmid">26223835</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blümcke</surname><given-names>I.</given-names></name><name><surname>Eggli</surname><given-names>P.</given-names></name><name><surname>Celio</surname><given-names>M. R.</given-names></name></person-group> (<year>1995</year>). <article-title>Relationship between astrocytic processes and “perineuronal nets” in rat neocortex.</article-title>
<source/><italic>Glia</italic>
<volume>15</volume>
<fpage>131</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440150205</pub-id>
<pub-id pub-id-type="pmid">8567064</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradbury</surname><given-names>E. J.</given-names></name><name><surname>Moon</surname><given-names>L. D.</given-names></name><name><surname>Popat</surname><given-names>R. J.</given-names></name><name><surname>King</surname><given-names>V. R.</given-names></name><name><surname>Bennett</surname><given-names>G. S.</given-names></name><name><surname>Patel</surname><given-names>P. N.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Chondroitinase ABC promotes functional recovery after spinal cord injury.</article-title>
<source/><italic>Nature</italic>
<volume>416</volume>
<fpage>636</fpage>–<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1038/416636a</pub-id>
<pub-id pub-id-type="pmid">11948352</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brauer</surname><given-names>K.</given-names></name><name><surname>Brückner</surname><given-names>G.</given-names></name><name><surname>Leibnitz</surname><given-names>L.</given-names></name><name><surname>Werner</surname><given-names>L.</given-names></name></person-group> (<year>1984</year>). <article-title>Structural and cytochemical features of perineuronal glial nets in the rat brain.</article-title>
<source/><italic>Acta Histochem.</italic>
<volume>74</volume>
<fpage>53</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-1281(84)80026-4</pub-id>
<pub-id pub-id-type="pmid">6203323</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brauer</surname><given-names>K.</given-names></name><name><surname>Werner</surname><given-names>L.</given-names></name><name><surname>Leibnitz</surname><given-names>L.</given-names></name></person-group> (<year>1982</year>). <article-title>Perineuronal nets of glia.</article-title>
<source/><italic>J. Brain Res.</italic>
<volume>23</volume>
<fpage>701</fpage>–<lpage>708</lpage>.</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brew</surname><given-names>K.</given-names></name><name><surname>Nagase</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1803</volume>
<fpage>55</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.01.003</pub-id>
<pub-id pub-id-type="pmid">20080133</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewton</surname><given-names>D. H.</given-names></name><name><surname>Kokash</surname><given-names>J.</given-names></name><name><surname>Jimenez</surname><given-names>O.</given-names></name><name><surname>Pena</surname><given-names>E. R.</given-names></name><name><surname>Razak</surname><given-names>K. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Age-related deterioration of perineuronal nets in the primary auditory cortex of mice.</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>8</volume>:<issue>270</issue>. <pub-id pub-id-type="doi">10.3389/fnagi.2016.00270</pub-id>
<pub-id pub-id-type="pmid">27877127</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brückner</surname><given-names>G.</given-names></name><name><surname>Brauer</surname><given-names>K.</given-names></name><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Wolff</surname><given-names>J. R.</given-names></name><name><surname>Rickmann</surname><given-names>M. J.</given-names></name><name><surname>Derouiche</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1993</year>). <article-title>Perineuronal nets provide a polyanionic, glia-associated form of microenviornment around certain neurons in many parts of the rat brain.</article-title>
<source/><italic>Glia</italic>
<volume>8</volume>
<fpage>183</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440080306</pub-id>
<pub-id pub-id-type="pmid">7693589</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brückner</surname><given-names>G.</given-names></name><name><surname>Grosche</surname><given-names>J.</given-names></name><name><surname>Schmidt</surname><given-names>S.</given-names></name><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Margolis</surname><given-names>R. U.</given-names></name><name><surname>Delpech</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Postnatal development of perineuronal nets in wild type mice and in a mutant deficient in tenascin R.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>428</volume>
<fpage>616</fpage>–<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1002/1096-9861(20001225)428:4&lt;616::AID-CNE3&gt;3.0.CO;2-K</pub-id>
<pub-id pub-id-type="pmid">11077416</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brückner</surname><given-names>G.</given-names></name><name><surname>Hausen</surname><given-names>D.</given-names></name><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Drlicek</surname><given-names>M.</given-names></name><name><surname>Arendt</surname><given-names>T.</given-names></name><name><surname>Brauer</surname><given-names>K.</given-names></name></person-group> (<year>1999</year>). <article-title>Cortical areas abundant in extracellular matrix chondroitin sulphate proteoglycans are less affected by cytoskeletal changes in Alzheimer’s disease.</article-title>
<source/><italic>Neuroscience</italic>
<volume>92</volume>
<fpage>719</fpage>–<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(99)00071-8</pub-id>
<pub-id pub-id-type="pmid">10426522</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruno</surname><given-names>M. A.</given-names></name><name><surname>Cuello</surname><given-names>A. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>6735</fpage>–<lpage>6740</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510645103</pub-id>
<pub-id pub-id-type="pmid">16618925</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabungcal</surname><given-names>J. H.</given-names></name><name><surname>Counotte</surname><given-names>D. S.</given-names></name><name><surname>Lewis</surname><given-names>E.</given-names></name><name><surname>Tejeda</surname><given-names>H. A.</given-names></name><name><surname>Piantadosi</surname><given-names>P.</given-names></name><name><surname>Pollock</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia.</article-title>
<source/><italic>Neuron</italic>
<volume>83</volume>
<fpage>1073</fpage>–<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.07.028</pub-id>
<pub-id pub-id-type="pmid">25132466</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabungcal</surname><given-names>J. H.</given-names></name><name><surname>Steullet</surname><given-names>P.</given-names></name><name><surname>Morishita</surname><given-names>H.</given-names></name><name><surname>Kraftsik</surname><given-names>R.</given-names></name><name><surname>Cuenod</surname><given-names>M.</given-names></name><name><surname>Hensch</surname><given-names>T. K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Perineuronal nets protect fast-spiking interneurons against oxidative stress.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>9130</fpage>–<lpage>9135</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1300454110</pub-id>
<pub-id pub-id-type="pmid">23671099</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cañas</surname><given-names>N.</given-names></name><name><surname>Valero</surname><given-names>T.</given-names></name><name><surname>Villarroya</surname><given-names>M.</given-names></name><name><surname>Montell</surname><given-names>E.</given-names></name><name><surname>Vergés</surname><given-names>J.</given-names></name><name><surname>García</surname><given-names>A. G.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing heme oxygenase-1 via phosphatidylinositol 3-kinase/AKT.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>323</volume>
<fpage>946</fpage>–<lpage>953</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.107.123505</pub-id>
<pub-id pub-id-type="pmid">17885094</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardin</surname><given-names>J. A.</given-names></name><name><surname>Carlén</surname><given-names>M.</given-names></name><name><surname>Meletis</surname><given-names>K.</given-names></name><name><surname>Knoblich</surname><given-names>U.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Deisseroth</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Driving fast-spiking cells induces gamma rhythm and controls sensory responses.</article-title>
<source/><italic>Nature</italic>
<volume>459</volume>
<fpage>663</fpage>–<lpage>667</lpage>. <pub-id pub-id-type="doi">10.1038/nature08002</pub-id>
<pub-id pub-id-type="pmid">19396156</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmichael</surname><given-names>S. T.</given-names></name><name><surname>Archibeque</surname><given-names>I.</given-names></name><name><surname>Luke</surname><given-names>L.</given-names></name><name><surname>Nolan</surname><given-names>T.</given-names></name><name><surname>Momiy</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>193</volume>
<fpage>291</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2005.01.004</pub-id>
<pub-id pub-id-type="pmid">15869933</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caspary</surname><given-names>D. M.</given-names></name><name><surname>Raza</surname><given-names>A.</given-names></name><name><surname>Lawhorn Armour</surname><given-names>B. A.</given-names></name><name><surname>Pippin</surname><given-names>J.</given-names></name><name><surname>Arneriæ</surname><given-names>S. P.</given-names></name></person-group> (<year>1990</year>). <article-title>Immunocytochemical and neurochemical evidence for age-related loss of GABA in the inferior colliculus: implications for neural presbycusis.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>10</volume>
<fpage>2363</fpage>–<lpage>2372</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.10-07-02363.1990</pub-id>
<pub-id pub-id-type="pmid">1973948</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castrén</surname><given-names>M.</given-names></name><name><surname>Pääkkönen</surname><given-names>A.</given-names></name><name><surname>Tarkka</surname><given-names>I. M.</given-names></name><name><surname>Ryynänen</surname><given-names>M.</given-names></name><name><surname>Partanen</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Augmentation of auditory N1 in children with fragile X syndrome.</article-title>
<source/><italic>Brain Topogr.</italic>
<volume>15</volume>
<fpage>165</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1023/A:1022606200636</pub-id>
<pub-id pub-id-type="pmid">12705812</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celio</surname><given-names>M. R.</given-names></name><name><surname>Blümcke</surname><given-names>I.</given-names></name></person-group> (<year>1994</year>). <article-title>Perineuronal nets—a specialized form of extracellular matrix in the adult nervous system.</article-title>
<source/><italic>Brain Res. Brain Res. Rev.</italic>
<volume>19</volume>
<fpage>128</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/0165-0173(94)90006-X</pub-id><pub-id pub-id-type="pmid">8167657</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celio</surname><given-names>M. R.</given-names></name><name><surname>Spreafico</surname><given-names>R.</given-names></name><name><surname>De Biasi</surname><given-names>S.</given-names></name><name><surname>Vitellaro-Zuccarello</surname><given-names>L.</given-names></name></person-group> (<year>1998</year>). <article-title>Perineuronal nets: past and present.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>21</volume>
<fpage>510</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-2236(98)01298-3</pub-id>
<pub-id pub-id-type="pmid">9881847</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>M. C.</given-names></name><name><surname>Park</surname><given-names>J. M.</given-names></name><name><surname>Pelkey</surname><given-names>K. A.</given-names></name><name><surname>Grabenstatter</surname><given-names>H. L.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Linden</surname><given-names>D. J.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons.</article-title>
<source/><italic>Nature</italic>
<volume>13</volume>
<fpage>1090</fpage>–<lpage>1097</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2621</pub-id>
<pub-id pub-id-type="pmid">20729843</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>M.</given-names></name><name><surname>Kaczmarek</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>MMP-9 inhibition: a therapeutic strategy in ischemic stroke.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>49</volume>
<fpage>563</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-013-8538-z</pub-id>
<pub-id pub-id-type="pmid">24026771</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirillo</surname><given-names>G.</given-names></name><name><surname>Colangelo</surname><given-names>A. M.</given-names></name><name><surname>De Luca</surname><given-names>C.</given-names></name><name><surname>Savarese</surname><given-names>L.</given-names></name><name><surname>Barillari</surname><given-names>M. R.</given-names></name><name><surname>Alberghina</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Modulation of matrix metalloproteinases activity in the ventral horn of the spinal cord re-stores neuroglial synaptic homeostasis and neurotrophic support following peripheral nerve injury.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0152750</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0152750</pub-id>
<pub-id pub-id-type="pmid">27028103</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirillo</surname><given-names>G.</given-names></name><name><surname>Di Pino</surname><given-names>G.</given-names></name><name><surname>Capone</surname><given-names>F.</given-names></name><name><surname>Ranieri</surname><given-names>F.</given-names></name><name><surname>Florio</surname><given-names>L.</given-names></name><name><surname>Todisco</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Neurobiological after-effects of non-invasive brain stimulation.</article-title>
<source/><italic>Brain Stimul.</italic>
<volume>10</volume>
<fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.brs.2016.11.009</pub-id>
<pub-id pub-id-type="pmid">27931886</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claes</surname><given-names>L.</given-names></name><name><surname>Del-Favero</surname><given-names>J.</given-names></name><name><surname>Ceulemans</surname><given-names>B.</given-names></name><name><surname>Lagae</surname><given-names>L.</given-names></name><name><surname>Van Broeckhoven</surname><given-names>C.</given-names></name><name><surname>De Jonghe</surname><given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>68</volume>
<fpage>1327</fpage>–<lpage>1332</lpage>. <pub-id pub-id-type="doi">10.1086/320609</pub-id>
<pub-id pub-id-type="pmid">11359211</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curley</surname><given-names>A. A.</given-names></name><name><surname>Arion</surname><given-names>D.</given-names></name><name><surname>Volk</surname><given-names>D. W.</given-names></name><name><surname>Asafu-Adjei</surname><given-names>J. K.</given-names></name><name><surname>Sampson</surname><given-names>A. R.</given-names></name><name><surname>Fish</surname><given-names>K. N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>168</volume>
<fpage>921</fpage>–<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2011.11010052</pub-id>
<pub-id pub-id-type="pmid">21632647</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dansie</surname><given-names>L. E.</given-names></name><name><surname>Phommahaxay</surname><given-names>K.</given-names></name><name><surname>Okusanya</surname><given-names>A. G.</given-names></name><name><surname>Uwadia</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Rotschafer</surname><given-names>S. E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.</article-title>
<source/><italic>Neuroscience</italic>
<volume>246</volume>
<fpage>186</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.04.058</pub-id>
<pub-id pub-id-type="pmid">23660195</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>S. J.</given-names></name><name><surname>Goucher</surname><given-names>D. R.</given-names></name><name><surname>Doller</surname><given-names>C.</given-names></name><name><surname>Silver</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>19</volume>
<fpage>5810</fpage>–<lpage>5822</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-14-05810.1999</pub-id><pub-id pub-id-type="pmid">10407022</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>J. M.</given-names></name><name><surname>Olin</surname><given-names>A. I.</given-names></name><name><surname>Murdoch</surname><given-names>A. D.</given-names></name><name><surname>Canfield</surname><given-names>A.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Timpl</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>12511</fpage>–<lpage>12518</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M400242200</pub-id>
<pub-id pub-id-type="pmid">14722076</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Felice</surname><given-names>F.</given-names></name><name><surname>Velasco</surname><given-names>P. T.</given-names></name><name><surname>Lambert</surname><given-names>M. P.</given-names></name><name><surname>Viola</surname><given-names>K.</given-names></name><name><surname>Fernandez</surname><given-names>S. J.</given-names></name><name><surname>Ferreira</surname><given-names>S. T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>282</volume>
<fpage>11590</fpage>–<lpage>11601</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M607483200</pub-id>
<pub-id pub-id-type="pmid">17308309</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>C.</given-names></name><name><surname>Papa</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Looking inside the matrix: perineuronal nets in plasticity, maladaptive plasticity and neurological disorders.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>41</volume>
<fpage>1507</fpage>–<lpage>1515</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-016-1876-2</pub-id>
<pub-id pub-id-type="pmid">26935742</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>C.</given-names></name><name><surname>Savarese</surname><given-names>L.</given-names></name><name><surname>Colangelo</surname><given-names>A. M.</given-names></name><name><surname>Bianco</surname><given-names>M. R.</given-names></name><name><surname>Cirillo</surname><given-names>G.</given-names></name><name><surname>Alberghina</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Astrocytes and microglia-mediated immune response in maladaptive plasticity is differently modulated by NGF in the ventral horn of the spinal cord following peripheral nerve injury.</article-title>
<source/><italic>Cell. Mol. Neurobiol.</italic>
<volume>36</volume>
<fpage>37</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-015-0218-2</pub-id>
<pub-id pub-id-type="pmid">26084599</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deibel</surname><given-names>M. A.</given-names></name><name><surname>Ehmann</surname><given-names>W. D.</given-names></name><name><surname>Markesbery</surname><given-names>W. R.</given-names></name></person-group> (<year>1996</year>). <article-title>Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>143</volume>
<fpage>137</fpage>–<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-510X(96)00203-1</pub-id>
<pub-id pub-id-type="pmid">8981312</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delpech</surname><given-names>A.</given-names></name><name><surname>Delpech</surname><given-names>B.</given-names></name></person-group> (<year>1984</year>). <article-title>Expression of hyaluronic acid-binding glycoprotein, hyaluronectin, in the developing rat embryo.</article-title>
<source/><italic>Dev. Biol.</italic>
<volume>101</volume>
<fpage>391</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(84)90153-2</pub-id>
<pub-id pub-id-type="pmid">6198226</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dityatev</surname><given-names>A.</given-names></name><name><surname>Brückner</surname><given-names>G.</given-names></name><name><surname>Dityateva</surname><given-names>G.</given-names></name><name><surname>Grosche</surname><given-names>J.</given-names></name><name><surname>Kleene</surname><given-names>R.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Activity-dependent formation and functions of chondroitin sulfate rich extracellular matrix of perineuronal nets.</article-title>
<source/><italic>Dev. Biol.</italic>
<volume>67</volume>
<fpage>570</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20361</pub-id>
<pub-id pub-id-type="pmid">17443809</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dityatev</surname><given-names>A.</given-names></name><name><surname>Rusakov</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular signals of plasticity at the tetrapartite synapse.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>21</volume>
<fpage>353</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2010.12.006</pub-id>
<pub-id pub-id-type="pmid">21277196</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname><given-names>K. Q.</given-names></name><name><surname>Trabesinger</surname><given-names>A. H.</given-names></name><name><surname>Kirsten-Krüger</surname><given-names>M.</given-names></name><name><surname>Lauer</surname><given-names>C. J.</given-names></name><name><surname>Dydak</surname><given-names>U.</given-names></name><name><surname>Hell</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>12</volume>
<fpage>3721</fpage>–<lpage>3728</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2000.00229.x</pub-id><pub-id pub-id-type="pmid">11029642</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dziembowska</surname><given-names>M.</given-names></name><name><surname>Pretto</surname><given-names>D. I.</given-names></name><name><surname>Janusz</surname><given-names>A.</given-names></name><name><surname>Kaczmarek</surname><given-names>L.</given-names></name><name><surname>Leigh</surname><given-names>M. J.</given-names></name><name><surname>Gabriel</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>High MMP-9 activity levels in fragile X syndrome are lowered by minocycline.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>161</volume>
<fpage>1897</fpage>–<lpage>1903</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36023</pub-id>
<pub-id pub-id-type="pmid">23824974</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enwright</surname><given-names>J. F.</given-names></name><name><surname>Sanapala</surname><given-names>S.</given-names></name><name><surname>Foglio</surname><given-names>A.</given-names></name><name><surname>Berry</surname><given-names>R.</given-names></name><name><surname>Fish</surname><given-names>K. N.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Reduced labeling of parvalbumin neurons and perineuronal nets in the dorsolateral prefrontal cortex of subjects with schizophrenia.</article-title>
<source/><italic>Neuropyschopharmacology</italic>
<volume>41</volume>
<fpage>2206</fpage>–<lpage>2214</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2016.24</pub-id>
<pub-id pub-id-type="pmid">26868058</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ethridge</surname><given-names>L. E.</given-names></name><name><surname>White</surname><given-names>S. P.</given-names></name><name><surname>Mosconi</surname><given-names>M. W.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Byerly</surname><given-names>M. J.</given-names></name><name><surname>Sweeney</surname><given-names>J. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>6</volume>:<issue>e787</issue>. <pub-id pub-id-type="doi">10.1038/tp.2016.48</pub-id>
<pub-id pub-id-type="pmid">27093069</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favuzzi</surname><given-names>E.</given-names></name><name><surname>Marques-Smith</surname><given-names>A.</given-names></name><name><surname>Deogracias</surname><given-names>R.</given-names></name><name><surname>Winterflood</surname><given-names>C. M.</given-names></name><name><surname>Sánchez-Aguilera</surname><given-names>A.</given-names></name><name><surname>Mantoan</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Activity-dependent gating of parvalbumin interneuron function by the perineuronal net protein brevican.</article-title>
<source/><italic>Neuron</italic>
<volume>95</volume>
<fpage>639</fpage>–<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.028</pub-id>
<pub-id pub-id-type="pmid">28712654</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>I.</given-names></name><name><surname>Oliver</surname><given-names>B.</given-names></name><name><surname>Russi</surname><given-names>A.</given-names></name><name><surname>Casas</surname><given-names>R.</given-names></name><name><surname>Rivera</surname><given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>123</volume>
<fpage>18</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/0022-510X(94)90198-8</pub-id>
<pub-id pub-id-type="pmid">8064311</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flatow</surname><given-names>J.</given-names></name><name><surname>Buckley</surname><given-names>P.</given-names></name><name><surname>Miller</surname><given-names>B. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Meta-analysis of oxidative stress in schizophrenia.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>74</volume>
<fpage>400</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.03.018</pub-id>
<pub-id pub-id-type="pmid">23683390</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankland</surname><given-names>P. W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Rosner</surname><given-names>B.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name><name><surname>Balleine</surname><given-names>B. W.</given-names></name><name><surname>Dykens</surname><given-names>E. M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Sensorimotor gating abnormalities in young males with fragile X syndrome and <italic>Fmr1</italic>-knockout mice.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>9</volume>
<fpage>417</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001432</pub-id>
<pub-id pub-id-type="pmid">14981523</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>J. R.</given-names></name><name><surname>Laurent</surname><given-names>T. C.</given-names></name><name><surname>Laurent</surname><given-names>U. B.</given-names></name></person-group> (<year>1997</year>). <article-title>Hyaluronan: its nature, distribution, functions and turnover.</article-title>
<source/><italic>J. Intern. Med.</italic>
<volume>242</volume>
<fpage>27</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2796.1997.00170.x</pub-id><pub-id pub-id-type="pmid">9260563</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frischknecht</surname><given-names>R.</given-names></name><name><surname>Seidenbecher</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>The crosstalk of hyaluronan-based extracellular matrix and synapses.</article-title>
<source/><italic>Neuron Glia Biol.</italic>
<volume>4</volume>
<fpage>249</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1017/S1740925X09990226</pub-id>
<pub-id pub-id-type="pmid">19811705</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>T.</given-names></name><name><surname>Sugawara</surname><given-names>T.</given-names></name><name><surname>Mazaki-Miyazaki</surname><given-names>E.</given-names></name><name><surname>Takahashi</surname><given-names>Y.</given-names></name><name><surname>Fukushima</surname><given-names>K.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Mutations of sodium channel α subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic–clonic seizures.</article-title>
<source/><italic>Brain</italic>
<volume>126</volume>
<fpage>531</fpage>–<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awg053</pub-id><pub-id pub-id-type="pmid">12566275</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galtrey</surname><given-names>C. M.</given-names></name><name><surname>Kwok</surname><given-names>J. C.</given-names></name><name><surname>Carulli</surname><given-names>D.</given-names></name><name><surname>Rhodes</surname><given-names>K. E.</given-names></name><name><surname>Fawcett</surname><given-names>J. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Distribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cord.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>27</volume>
<fpage>1373</fpage>–<lpage>1390</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06108.x</pub-id>
<pub-id pub-id-type="pmid">18364019</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandal</surname><given-names>M. J.</given-names></name><name><surname>Edgar</surname><given-names>J. C.</given-names></name><name><surname>Klook</surname><given-names>K.</given-names></name><name><surname>Siegel</surname><given-names>S. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>62</volume>
<fpage>1504</fpage>–<lpage>1518</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.02.007</pub-id>
<pub-id pub-id-type="pmid">21349276</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Ma</surname><given-names>W.</given-names></name><name><surname>Ren</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Decreased auditory GABA + concentrations in presbycusis demonstrated by edited magnetic resonance.</article-title>
<source/><italic>Neuroimage</italic>
<volume>106</volume>
<fpage>311</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.11.023</pub-id>
<pub-id pub-id-type="pmid">25463460</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gary</surname><given-names>S. C.</given-names></name><name><surname>Zerillo</surname><given-names>C. A.</given-names></name><name><surname>Chiang</surname><given-names>V. L.</given-names></name><name><surname>Gaw</surname><given-names>J. U.</given-names></name><name><surname>Gray</surname><given-names>G.</given-names></name><name><surname>Hockfield</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma.</article-title>
<source/><italic>Gene</italic>
<volume>256</volume>
<fpage>139</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1119(00)00362-0</pub-id>
<pub-id pub-id-type="pmid">11054543</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gates</surname><given-names>G.</given-names></name><name><surname>Mills</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Presbycusis.</article-title>
<source/><italic>Lancet</italic>
<volume>366</volume>
<fpage>1111</fpage>–<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)67423-5</pub-id><pub-id pub-id-type="pmid">16182900</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giamanco</surname><given-names>K. A.</given-names></name><name><surname>Morawski</surname><given-names>M.</given-names></name><name><surname>Matthews</surname><given-names>R. T.</given-names></name></person-group> (<year>2010</year>). <article-title>Perineuronal net formation and structure in aggrecan knockout mice.</article-title>
<source/><italic>Neuroscience</italic>
<volume>170</volume>
<fpage>1314</fpage>–<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.08.032</pub-id>
<pub-id pub-id-type="pmid">20732394</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>J. R.</given-names></name><name><surname>Bartley</surname><given-names>A. F.</given-names></name><name><surname>Hays</surname><given-names>S. A.</given-names></name><name><surname>Huber</surname><given-names>K. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>100</volume>
<fpage>2615</fpage>–<lpage>2626</lpage>. <pub-id pub-id-type="doi">10.1152/jn.90752.2008</pub-id>
<pub-id pub-id-type="pmid">18784272</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glausier</surname><given-names>J. R.</given-names></name><name><surname>Fish</surname><given-names>K. N.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>30</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.152</pub-id>
<pub-id pub-id-type="pmid">24217255</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golgi</surname><given-names>C.</given-names></name></person-group> (<year>1893</year>). <article-title>Intorno all’origine del quarto nervo cerebrale e una questione istofisiologica che a questo argomento si collega.</article-title>
<source/><italic>Rend. R Accademia Lincei</italic>
<volume>2</volume>
<fpage>378</fpage>–<lpage>389</lpage>.</mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomis-Rüth</surname><given-names>F. X.</given-names></name><name><surname>Maskos</surname><given-names>K.</given-names></name><name><surname>Betz</surname><given-names>M.</given-names></name><name><surname>Bergner</surname><given-names>A.</given-names></name><name><surname>Huber</surname><given-names>R.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.</article-title>
<source/><italic>Nature</italic>
<volume>389</volume>
<fpage>77</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1038/37995</pub-id>
<pub-id pub-id-type="pmid">9288970</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>M. C.</given-names></name><name><surname>Worley</surname><given-names>P.</given-names></name><name><surname>Kirkwood</surname><given-names>A.</given-names></name><name><surname>Quinlan</surname><given-names>E. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Obligatory role for the immediate early gene NARP in critical period plasticity.</article-title>
<source/><italic>Neuron</italic>
<volume>79</volume>
<fpage>335</fpage>–<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.05.016</pub-id>
<pub-id pub-id-type="pmid">23889936</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>J.</given-names></name><name><surname>Vasan</surname><given-names>R. S.</given-names></name><name><surname>Ärnlöv</surname><given-names>J.</given-names></name><name><surname>Ingelsson</surname><given-names>E.</given-names></name><name><surname>Lind</surname><given-names>L.</given-names></name><name><surname>Larsson</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e16185</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016185</pub-id>
<pub-id pub-id-type="pmid">21283828</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>N. G.</given-names></name><name><surname>Mironova</surname><given-names>Y. A.</given-names></name><name><surname>Hovda</surname><given-names>D. A.</given-names></name><name><surname>Sutton</surname><given-names>R. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Pericontusion axon sprouting is spatially and temporally consistent with a growth-permissive environment after traumatic brain injury.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>69</volume>
<fpage>139</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e3181cb5bee</pub-id>
<pub-id pub-id-type="pmid">20084019</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Appel</surname><given-names>S.</given-names></name><name><surname>Suttkus</surname><given-names>A.</given-names></name><name><surname>Grosche</surname><given-names>J.</given-names></name><name><surname>Michalski</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Abolished perineuronal nets and altered parvalbumin-immunoreactivity in the nucleus reticularis thalami of wildtype and 3xTg mice after experimental stroke.</article-title>
<source/><italic>Neuroscience</italic>
<volume>337</volume>
<fpage>66</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.09.004</pub-id>
<pub-id pub-id-type="pmid">27634771</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Brauer</surname><given-names>K.</given-names></name><name><surname>Brückner</surname><given-names>G.</given-names></name></person-group> (<year>1992</year>). <article-title>Wisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons.</article-title>
<source/><italic>Neuroreport</italic>
<volume>3</volume>
<fpage>869</fpage>–<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199210000-00012</pub-id>
<pub-id pub-id-type="pmid">1421090</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Derouiche</surname><given-names>A.</given-names></name><name><surname>Welt</surname><given-names>K.</given-names></name><name><surname>Brauer</surname><given-names>K.</given-names></name><name><surname>Grosche</surname><given-names>J.</given-names></name><name><surname>Mäder</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Cortical neurons immunoreactive for the potassium channel Kv3.1b subunit are predominantly surrounded by perineuronal nets presumed as a buffering system for cations.</article-title>
<source/><italic>Brain Res.</italic>
<volume>842</volume>
<fpage>15</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(99)01784-9</pub-id>
<pub-id pub-id-type="pmid">10526091</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Mages</surname><given-names>B.</given-names></name><name><surname>Aleithe</surname><given-names>S.</given-names></name><name><surname>Nitzsche</surname><given-names>B.</given-names></name><name><surname>Altmann</surname><given-names>S.</given-names></name><name><surname>Barthel</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Damaged neocortical perineuronal nets due to experimental focal cerebral ischemia in mice. rats and sheep.</article-title>
<source/><italic>Front. Intergr. Neurosci.</italic>
<volume>11</volume>:<issue>15</issue>. <pub-id pub-id-type="doi">10.3389/fnint.2017.00015</pub-id>
<pub-id pub-id-type="pmid">28860977</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasenstaub</surname><given-names>A.</given-names></name><name><surname>Otte</surname><given-names>S.</given-names></name><name><surname>Callaway</surname><given-names>E.</given-names></name><name><surname>Sejnowski</surname><given-names>T. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Metabolic cost as a unifying principle governing neuronal biophysics.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>12329</fpage>–<lpage>12334</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0914886107</pub-id>
<pub-id pub-id-type="pmid">20616090</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T.</given-names></name><name><surname>Arion</surname><given-names>D.</given-names></name><name><surname>Unger</surname><given-names>T.</given-names></name><name><surname>Maldonado-Avilés</surname><given-names>J. G.</given-names></name><name><surname>Morris</surname><given-names>H. M.</given-names></name><name><surname>Volk</surname><given-names>D. W.</given-names></name><etal></etal></person-group> (<year>2008a</year>). <article-title>Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>13</volume>
<fpage>147</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="pmid">17471287</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T.</given-names></name><name><surname>Bazmi</surname><given-names>H. H.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Sampson</surname><given-names>A. R.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name></person-group> (<year>2008b</year>). <article-title>Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>165</volume>
<fpage>479</fpage>–<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2007.07081223</pub-id>
<pub-id pub-id-type="pmid">18281411</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T.</given-names></name><name><surname>Volk</surname><given-names>D. W.</given-names></name><name><surname>Eggan</surname><given-names>S. M.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name><name><surname>Pierri</surname><given-names>J. N.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>23</volume>
<fpage>6315</fpage>–<lpage>6326</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-15-06315.2003</pub-id>
<pub-id pub-id-type="pmid">12867516</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname><given-names>W. A.</given-names></name></person-group> (<year>1992</year>). <article-title>The natural history of drug resistant epilepsy: epidemiologic considerations.</article-title>
<source/><italic>Epilepsy Res. Suppl.</italic>
<volume>5</volume>
<fpage>25</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="pmid">1418457</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedrich</surname><given-names>U. B.</given-names></name><name><surname>Liautard</surname><given-names>C.</given-names></name><name><surname>Kirschenbaum</surname><given-names>D.</given-names></name><name><surname>Pofahl</surname><given-names>M.</given-names></name><name><surname>Lavigne</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Impaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human NaV1.1 mutation.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>14874</fpage>–<lpage>14889</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0721-14.2014</pub-id>
<pub-id pub-id-type="pmid">25378155</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensch</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Critical period plasticity in local cortical circuits.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>6</volume>
<fpage>877</fpage>–<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1787</pub-id>
<pub-id pub-id-type="pmid">16261181</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobohm</surname><given-names>C.</given-names></name><name><surname>Günther</surname><given-names>A.</given-names></name><name><surname>Grosche</surname><given-names>J.</given-names></name><name><surname>Rossner</surname><given-names>S.</given-names></name><name><surname>Schneider</surname><given-names>D.</given-names></name><name><surname>Brückner</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>80</volume>
<fpage>539</fpage>–<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.20459</pub-id>
<pub-id pub-id-type="pmid">15806566</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoover</surname><given-names>B. R.</given-names></name><name><surname>Reed</surname><given-names>M. N.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Penrod</surname><given-names>R. D.</given-names></name><name><surname>Kotilinek</surname><given-names>L. A.</given-names></name><name><surname>Grant</surname><given-names>M. K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.</article-title>
<source/><italic>Neuron</italic>
<volume>68</volume>
<fpage>1067</fpage>–<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.11.030</pub-id>
<pub-id pub-id-type="pmid">21172610</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inan</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Manuszak</surname><given-names>M.</given-names></name><name><surname>Karakaya</surname><given-names>C.</given-names></name><name><surname>Rajadhyaksha</surname><given-names>A. M.</given-names></name><name><surname>Pickel</surname><given-names>V. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>93</volume>
<fpage>35</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.04.004</pub-id>
<pub-id pub-id-type="pmid">27105708</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irvine</surname><given-names>S. F.</given-names></name><name><surname>Kwok</surname><given-names>J. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Perineuronal nets in spinal motoneurones: chondroitin sulphate proteoglycan around alpha motoneurones.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>1172</issue>. <pub-id pub-id-type="doi">10.3390/ijms19041172</pub-id>
<pub-id pub-id-type="pmid">29649136</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janusz</surname><given-names>A.</given-names></name><name><surname>Milek</surname><given-names>J.</given-names></name><name><surname>Perycz</surname><given-names>M.</given-names></name><name><surname>Pacini</surname><given-names>L.</given-names></name><name><surname>Bagni</surname><given-names>C.</given-names></name><name><surname>Kaczmarek</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>18234</fpage>–<lpage>18241</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2207-13.2013</pub-id>
<pub-id pub-id-type="pmid">24227732</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaas</surname><given-names>J. H.</given-names></name><name><surname>Qi</surname><given-names>H. X.</given-names></name><name><surname>Burish</surname><given-names>M. J.</given-names></name><name><surname>Gharbawie</surname><given-names>O. A.</given-names></name><name><surname>Onifer</surname><given-names>S. M.</given-names></name><name><surname>Massey</surname><given-names>J. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Cortical and subcortical plasticity in the brains of humans, primates, and rats after damage to sensory afferents in the dorsal columns of the spinal cord.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>209</volume>
<fpage>407</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2007.06.014</pub-id>
<pub-id pub-id-type="pmid">17692844</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kann</surname><given-names>O.</given-names></name><name><surname>Papageorgiou</surname><given-names>I. E.</given-names></name><name><surname>Draguhn</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Highly energized inhibitory interneurons are a central element for information processing in cortical networks.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>34</volume>
<fpage>1270</fpage>–<lpage>1282</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2014.104</pub-id>
<pub-id pub-id-type="pmid">24896567</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karetko</surname><given-names>M.</given-names></name><name><surname>Skangiel-Kramska</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Diverse functions of perineuronal nets.</article-title>
<source/><italic>Acta Neurobiol. Exp.</italic>
<volume>69</volume>
<fpage>564</fpage>–<lpage>577</lpage>.</mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karetko-Sysa</surname><given-names>M.</given-names></name><name><surname>Skangiel-Kramska</surname><given-names>J.</given-names></name><name><surname>Nowicka</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Aging somatosensory cortex displays increased density of WFA-binding perineuronal nets associated with GAD-negative neurons.</article-title>
<source/><italic>Neuroscience</italic>
<volume>277</volume>
<fpage>734</fpage>–<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.07.049</pub-id>
<pub-id pub-id-type="pmid">25086318</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khodaie-Ardakani</surname><given-names>M. R.</given-names></name><name><surname>Mirshafiee</surname><given-names>O.</given-names></name><name><surname>Farokhnia</surname><given-names>M.</given-names></name><name><surname>Tajdini</surname><given-names>M.</given-names></name><name><surname>Hosseini</surname><given-names>S. M.</given-names></name><name><surname>Modabbernia</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.</article-title>
<source/><italic>Psychiatry Res.</italic>
<volume>215</volume>
<fpage>540</fpage>–<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2013.12.051</pub-id>
<pub-id pub-id-type="pmid">24480077</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>G. W.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Cho</surname><given-names>K. J.</given-names></name><name><surname>Kim</surname><given-names>H. W.</given-names></name><name><surname>Cho</surname><given-names>Y. J.</given-names></name><name><surname>Lee</surname><given-names>B. I.</given-names></name></person-group> (<year>2009</year>). <article-title>The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>36</volume>
<fpage>169</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.07.008</pub-id>
<pub-id pub-id-type="pmid">19631748</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. Y.</given-names></name><name><surname>Porter</surname><given-names>B. E.</given-names></name><name><surname>Friedman</surname><given-names>A.</given-names></name><name><surname>Kaufer</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>A potential role for glia-derived extracellular matrix remodeling in postinjury epilepsy.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>94</volume>
<fpage>794</fpage>–<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23758</pub-id>
<pub-id pub-id-type="pmid">27265805</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köppe</surname><given-names>G.</given-names></name><name><surname>Brückner</surname><given-names>G.</given-names></name><name><surname>Brauer</surname><given-names>K.</given-names></name><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Bigl</surname><given-names>V.</given-names></name></person-group> (<year>1997</year>). <article-title>Developmental patterns of proteoglycan-containing extracellular matrix in perineuronal nets and neuropil of the postnatal rat brain.</article-title>
<source/><italic>Cell Tissue Res.</italic>
<volume>288</volume>
<fpage>33</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s004410050790</pub-id>
<pub-id pub-id-type="pmid">9042770</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosaka</surname><given-names>T.</given-names></name><name><surname>Heizmann</surname><given-names>C. W.</given-names></name></person-group> (<year>1989</year>). <article-title>Selective staining of a population of parvalbumin-containing GABAergic neurons in the rat cerebral cortex by lectins with specific affinity for terminal N-acetylgalactosamine.</article-title>
<source/><italic>Brain Res.</italic>
<volume>483</volume>
<fpage>158</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(89)90048-6</pub-id>
<pub-id pub-id-type="pmid">2565147</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwok</surname><given-names>J. C.</given-names></name><name><surname>Dick</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Fawcett</surname><given-names>J. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Extracellular matrix and perineuronal nets in CNS repair.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>71</volume>
<fpage>1073</fpage>–<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20974</pub-id>
<pub-id pub-id-type="pmid">21898855</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>J. S.</given-names></name><name><surname>O’Donnell</surname><given-names>B. F.</given-names></name><name><surname>Wallenstein</surname><given-names>G. V.</given-names></name><name><surname>Greene</surname><given-names>R. W.</given-names></name><name><surname>Hirayasu</surname><given-names>Y.</given-names></name><name><surname>Nestor</surname><given-names>P. G.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Gamma frequency–range abnormalities to auditory stimulation in schizophrenia.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>56</volume>
<fpage>1001</fpage>–<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.56.11.1001</pub-id><pub-id pub-id-type="pmid">10565499</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarus</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name></person-group> (<year>2011</year>). <article-title>Distinct maturation profiles of perisomatic and dendritic targeting GABAergic interneurons in the mouse primary visual cortex during the critical period of ocular dominance plasticity.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>106</volume>
<fpage>775</fpage>–<lpage>787</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00729.2010</pub-id>
<pub-id pub-id-type="pmid">21613595</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Yao</surname><given-names>J. S.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Zhai</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Guglielmo</surname><given-names>B. J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Dose–response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation.</article-title>
<source/><italic>J. Cereb. Blood Flow Metab.</italic>
<volume>26</volume>
<fpage>1157</fpage>–<lpage>1164</lpage>. <pub-id pub-id-type="doi">10.1038/sj.jcbfm.9600268</pub-id>
<pub-id pub-id-type="pmid">16395286</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leigh</surname><given-names>M. J.</given-names></name><name><surname>Nguyen</surname><given-names>D. V.</given-names></name><name><surname>Mu</surname><given-names>Y.</given-names></name><name><surname>Winarni</surname><given-names>T. I.</given-names></name><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Chechi</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with Fragile X Syndrome.</article-title>
<source/><italic>J. Dev. Behav. Pediatr.</italic>
<volume>34</volume>
<fpage>147</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1097/DBP.0b013e318287cd17</pub-id>
<pub-id pub-id-type="pmid">23572165</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemarchant</surname><given-names>S.</given-names></name><name><surname>Pruvost</surname><given-names>M.</given-names></name><name><surname>Montaner</surname><given-names>J.</given-names></name><name><surname>Emery</surname><given-names>E.</given-names></name><name><surname>Vivien</surname><given-names>D.</given-names></name><name><surname>Kanninen</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>ADAMTS proteoglycanases in the physiological and pathological central nervous system.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>10</volume>:<issue>133</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-10-133</pub-id>
<pub-id pub-id-type="pmid">24176075</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lendvai</surname><given-names>D.</given-names></name><name><surname>Morawski</surname><given-names>M.</given-names></name><name><surname>Négyessy</surname><given-names>L.</given-names></name><name><surname>Gáti</surname><given-names>G.</given-names></name><name><surname>Jäger</surname><given-names>C.</given-names></name><name><surname>Baksa</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer’s disease.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>125</volume>
<fpage>215</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-012-1042-0</pub-id>
<pub-id pub-id-type="pmid">22961619</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lensjø</surname><given-names>K. K.</given-names></name><name><surname>Lepperød</surname><given-names>M. E.</given-names></name><name><surname>Dick</surname><given-names>G.</given-names></name><name><surname>Hafting</surname><given-names>T.</given-names></name><name><surname>Fyhn</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Removal of perineuronal nets unlocks juvenile plasticity through network mechanisms of decreased inhibition and increased gamma activity.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>1269</fpage>–<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2504-16.2016</pub-id>
<pub-id pub-id-type="pmid">28039374</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lepeta</surname><given-names>K.</given-names></name><name><surname>Purzycka</surname><given-names>K. J.</given-names></name><name><surname>Pachulska-Wieczorek</surname><given-names>K.</given-names></name><name><surname>Mitjans</surname><given-names>M.</given-names></name><name><surname>Begemann</surname><given-names>M.</given-names></name><name><surname>Vafadari</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms.</article-title>
<source/><italic>EMBO Mol. Med.</italic>
<volume>9</volume>
<fpage>1100</fpage>–<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201707723</pub-id>
<pub-id pub-id-type="pmid">28623238</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levkovitz</surname><given-names>Y.</given-names></name><name><surname>Mendlovich</surname><given-names>S.</given-names></name><name><surname>Riwkes</surname><given-names>S.</given-names></name><name><surname>Braw</surname><given-names>Y.</given-names></name><name><surname>Levkovitch-Verbin</surname><given-names>H.</given-names></name><name><surname>Gal</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.</article-title>
<source/><italic>J. Clin. Psychiatry</italic>
<volume>71</volume>
<fpage>138</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.4088/JCP.08m04666yel</pub-id>
<pub-id pub-id-type="pmid">19895780</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Light</surname><given-names>G. A.</given-names></name><name><surname>Hsu</surname><given-names>J. L.</given-names></name><name><surname>Hsieh</surname><given-names>M. H.</given-names></name><name><surname>Meyer-Gomes</surname><given-names>K.</given-names></name><name><surname>Sprock</surname><given-names>J.</given-names></name><name><surname>Swerdlow</surname><given-names>N. R.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>60</volume>
<fpage>1231</fpage>–<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.03.055</pub-id>
<pub-id pub-id-type="pmid">16893524</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Gao</surname><given-names>P. F.</given-names></name><name><surname>Xu</surname><given-names>H. W.</given-names></name><name><surname>Liu</surname><given-names>M. M.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Yao</surname><given-names>J. P.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Perineuronal nets increase inhibitory GABAergic currents during the critical period in rats.</article-title>
<source/><italic>Int. J. Opthalmol.</italic>
<volume>6</volume>
<fpage>120</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.3980/j.issn.2222-3959.2013.02.02</pub-id>
<pub-id pub-id-type="pmid">23638408</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Akamatsu</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>C. C.</given-names></name><name><surname>Stetler</surname><given-names>R. A.</given-names></name><name><surname>Lawton</surname><given-names>M. T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>115</volume>
<fpage>138</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.11.004</pub-id>
<pub-id pub-id-type="pmid">24291532</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzl</surname><given-names>S.</given-names></name><name><surname>Albers</surname><given-names>D. S.</given-names></name><name><surname>Relkin</surname><given-names>N.</given-names></name><name><surname>Ngyuen</surname><given-names>T.</given-names></name><name><surname>Hilgenberg</surname><given-names>S. L.</given-names></name><name><surname>Chirichigno</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s disease.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>43</volume>
<fpage>191</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/S0197-0186(03)00004-4</pub-id><pub-id pub-id-type="pmid">12689599</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovelace</surname><given-names>J. W.</given-names></name><name><surname>Ethell</surname><given-names>I. M.</given-names></name><name><surname>Binder</surname><given-names>D. K.</given-names></name><name><surname>Razak</surname><given-names>K. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>115</volume>
<fpage>39</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2018.03.012</pub-id>
<pub-id pub-id-type="pmid">29605426</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovelace</surname><given-names>J. W.</given-names></name><name><surname>Wen</surname><given-names>T. H.</given-names></name><name><surname>Reinhard</surname><given-names>S.</given-names></name><name><surname>Hsu</surname><given-names>M. S.</given-names></name><name><surname>Sidhu</surname><given-names>H.</given-names></name><name><surname>Ethell</surname><given-names>I. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of fragile X syndrome.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>89</volume>
<fpage>126</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.02.002</pub-id>
<pub-id pub-id-type="pmid">26850918</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madinier</surname><given-names>A.</given-names></name><name><surname>Quattromani</surname><given-names>M. J.</given-names></name><name><surname>Sjölund</surname><given-names>C.</given-names></name><name><surname>Ruscher</surname><given-names>K.</given-names></name><name><surname>Wieloch</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Enriched housing enhances recovery of limb placement ability and reduces aggrecan-containing perineuronal nets in the rat somatosensory cortex after experimental stroke.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e93121</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0093121</pub-id>
<pub-id pub-id-type="pmid">24664200</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>S. H.</given-names></name><name><surname>Sumer</surname><given-names>E. U.</given-names></name><name><surname>Bay-Jensen</surname><given-names>A. C.</given-names></name><name><surname>Sondergaard</surname><given-names>B. C.</given-names></name><name><surname>Qvist</surname><given-names>P.</given-names></name><name><surname>Karsdal</surname><given-names>M. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Aggrecanase-and matrix metalloproteinase-mediated aggrecan degradation is associated with different molecular characteristics of aggrecan and separated in time ex vivo.</article-title>
<source/><italic>Biomarkers</italic>
<volume>15</volume>
<fpage>266</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.3109/13547500903521810</pub-id>
<pub-id pub-id-type="pmid">20039789</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manczak</surname><given-names>M.</given-names></name><name><surname>Anekonda</surname><given-names>T. S.</given-names></name><name><surname>Henson</surname><given-names>E.</given-names></name><name><surname>Park</surname><given-names>B. S.</given-names></name><name><surname>Quinn</surname><given-names>J.</given-names></name><name><surname>Reddy</surname><given-names>P. H.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Mitochondria are a direct site of Aβ accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>15</volume>
<fpage>1437</fpage>–<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl066</pub-id>
<pub-id pub-id-type="pmid">16551656</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin del Campo</surname><given-names>H. N.</given-names></name><name><surname>Measor</surname><given-names>K. R.</given-names></name><name><surname>Razak</surname><given-names>K. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Parvalbumin immunoreactivity in the auditory cortex of a mouse model of presbycusis.</article-title>
<source/><italic>Hear. Res.</italic>
<volume>294</volume>
<fpage>31</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.heares.2012.08.017</pub-id>
<pub-id pub-id-type="pmid">23010334</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massey</surname><given-names>J. M.</given-names></name><name><surname>Amps</surname><given-names>J.</given-names></name><name><surname>Viapiano</surname><given-names>M. S.</given-names></name><name><surname>Matthews</surname><given-names>R. T.</given-names></name><name><surname>Wagoner</surname><given-names>M. R.</given-names></name><name><surname>Whitaker</surname><given-names>C. M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>209</volume>
<fpage>426</fpage>–<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2007.03.029</pub-id>
<pub-id pub-id-type="pmid">17540369</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massey</surname><given-names>J. M.</given-names></name><name><surname>Hubscher</surname><given-names>C. H.</given-names></name><name><surname>Wagoner</surname><given-names>M. R.</given-names></name><name><surname>Decker</surname><given-names>J. A.</given-names></name><name><surname>Amps</surname><given-names>J.</given-names></name><name><surname>Silver</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>4406</fpage>–<lpage>4414</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5467-05.2006</pub-id>
<pub-id pub-id-type="pmid">16624960</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>R. T.</given-names></name><name><surname>Kelly</surname><given-names>G. M.</given-names></name><name><surname>Zerillo</surname><given-names>C. A.</given-names></name><name><surname>Gray</surname><given-names>G.</given-names></name><name><surname>Tiemeyer</surname><given-names>M.</given-names></name><name><surname>Hockfield</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>22</volume>
<fpage>7536</fpage>–<lpage>7547</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-17-07536.2002</pub-id><pub-id pub-id-type="pmid">12196577</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauney</surname><given-names>S. A.</given-names></name><name><surname>Athanas</surname><given-names>K. M.</given-names></name><name><surname>Pantazopoulos</surname><given-names>H.</given-names></name><name><surname>Shaskan</surname><given-names>N.</given-names></name><name><surname>Passeri</surname><given-names>E.</given-names></name><name><surname>Berretta</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>74</volume>
<fpage>427</fpage>–<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.05.007</pub-id>
<pub-id pub-id-type="pmid">23790226</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McRae</surname><given-names>P.</given-names></name><name><surname>Porter</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>The perineuronal net component of the extracellular matrix in plasticity and epilepsy.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>61</volume>
<fpage>963</fpage>–<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2012.08.007</pub-id>
<pub-id pub-id-type="pmid">22954428</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellios</surname><given-names>N.</given-names></name><name><surname>Huang</surname><given-names>H. S.</given-names></name><name><surname>Baker</surname><given-names>S. P.</given-names></name><name><surname>Galdzicka</surname><given-names>M.</given-names></name><name><surname>Ginns</surname><given-names>E.</given-names></name><name><surname>Akbarian</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>65</volume>
<fpage>1006</fpage>–<lpage>1014</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.11.019</pub-id>
<pub-id pub-id-type="pmid">19121517</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercuri</surname><given-names>F. A.</given-names></name><name><surname>Maciewicz</surname><given-names>R. A.</given-names></name><name><surname>Tart</surname><given-names>J.</given-names></name><name><surname>Last</surname><given-names>K.</given-names></name><name><surname>Fosang</surname><given-names>A. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>33038</fpage>–<lpage>33045</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.42.33038</pub-id>
<pub-id pub-id-type="pmid">11032846</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Puttlitz</surname><given-names>B.</given-names></name><name><surname>Junker</surname><given-names>E.</given-names></name><name><surname>Margolis</surname><given-names>R. U.</given-names></name><name><surname>Margolis</surname><given-names>R. K.</given-names></name></person-group> (<year>1996</year>). <article-title>Chondroitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localization of neurocan and phosphacan.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>366</volume>
<fpage>44</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19960226)366:1&lt;44::AID-CNE4&gt;3.0.CO;2-K</pub-id>
<pub-id pub-id-type="pmid">8866845</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milev</surname><given-names>P.</given-names></name><name><surname>Maurel</surname><given-names>P.</given-names></name><name><surname>Chiba</surname><given-names>A.</given-names></name><name><surname>Mevissen</surname><given-names>M.</given-names></name><name><surname>Popp</surname><given-names>S.</given-names></name><name><surname>Yamaguchi</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>247</volume>
<fpage>207</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1998.8759</pub-id>
<pub-id pub-id-type="pmid">9642104</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>B.</given-names></name><name><surname>Sheppard</surname><given-names>A. M.</given-names></name><name><surname>Bicknese</surname><given-names>A. R.</given-names></name><name><surname>Pearlman</surname><given-names>A. L.</given-names></name></person-group> (<year>1996</year>). <article-title>Chondroitin sulphate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>355</volume>
<fpage>615</fpage>–<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903550410</pub-id>
<pub-id pub-id-type="pmid">7636035</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaoka</surname><given-names>T.</given-names></name><name><surname>Yasukawa</surname><given-names>R.</given-names></name><name><surname>Yasuda</surname><given-names>H.</given-names></name><name><surname>Hayashida</surname><given-names>M.</given-names></name><name><surname>Inagaki</surname><given-names>T.</given-names></name><name><surname>Horiguchi</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Minocycline as adjunctive therapy for schizophrenia: an open-label study.</article-title>
<source/><italic>Clin. Neuropharmacol.</italic>
<volume>31</volume>
<fpage>287</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1097/WNF.0b013e3181593d45</pub-id>
<pub-id pub-id-type="pmid">18836347</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>S.</given-names></name><name><surname>Nishimura</surname><given-names>Y.</given-names></name><name><surname>Nakashima</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Perineuronal nets protect against amyloid β-protein neurotoxicity in cultured cortical neurons.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1150</volume>
<fpage>200</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2007.02.066</pub-id>
<pub-id pub-id-type="pmid">17397805</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>A.</given-names></name><name><surname>Wehr</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Parvalbumin-expressing inhibitory interneurons in auditory cortex are well-tuned for frequency.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>13713</fpage>–<lpage>13723</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0663-13.2013</pub-id>
<pub-id pub-id-type="pmid">23966693</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morawski</surname><given-names>M.</given-names></name><name><surname>Brückner</surname><given-names>G.</given-names></name><name><surname>Jäger</surname><given-names>C.</given-names></name><name><surname>Seeger</surname><given-names>G.</given-names></name><name><surname>Arendt</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer’s disease.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>169</volume>
<fpage>1347</fpage>–<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.05.022</pub-id>
<pub-id pub-id-type="pmid">20497908</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morawski</surname><given-names>M.</given-names></name><name><surname>Brückner</surname><given-names>M. K.</given-names></name><name><surname>Riederer</surname><given-names>P.</given-names></name><name><surname>Brückner</surname><given-names>G.</given-names></name><name><surname>Arendt</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Perineuronal nets potentially protect against oxidative stress.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>188</volume>
<fpage>309</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2004.04.017</pub-id>
<pub-id pub-id-type="pmid">15246831</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morishita</surname><given-names>H.</given-names></name><name><surname>Cabungcal</surname><given-names>J. H.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Do</surname><given-names>K. Q.</given-names></name><name><surname>Hensch</surname><given-names>T. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Prolonged period of cortical plasticity upon redox dysregulation in fast-spiking interneurons.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>78</volume>
<fpage>396</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2014.12.026</pub-id>
<pub-id pub-id-type="pmid">25758057</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murase</surname><given-names>S.</given-names></name><name><surname>Lantz</surname><given-names>C. L.</given-names></name><name><surname>Quinlan</surname><given-names>E. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Light reintroduction after dark exposure reactivates plasticity in adults via perisynaptic activation of MMP-9.</article-title>
<source/><italic>eLife</italic>
<volume>6</volume>:<issue>e27345</issue>. <pub-id pub-id-type="doi">10.7554/eLife.27345</pub-id>
<pub-id pub-id-type="pmid">28875930</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>J.</given-names></name><name><surname>Cuckle</surname><given-names>H.</given-names></name><name><surname>Taylor</surname><given-names>G.</given-names></name><name><surname>Hewison</surname><given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>Screening for fragile X syndrome.</article-title>
<source/><italic>Health Technol. Assess.</italic>
<volume>1</volume> i–iv, <fpage>1</fpage>–<lpage>71</lpage>.</mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musumeci</surname><given-names>S. A.</given-names></name><name><surname>Bosco</surname><given-names>P.</given-names></name><name><surname>Calabrese</surname><given-names>G.</given-names></name><name><surname>Bakker</surname><given-names>C.</given-names></name><name><surname>De Sarro</surname><given-names>G. B.</given-names></name><name><surname>Elia</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.</article-title>
<source/><italic>Epilepsia</italic>
<volume>41</volume>
<fpage>19</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1157.2000.tb01499.x</pub-id><pub-id pub-id-type="pmid">10643918</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>F.</given-names></name><name><surname>Schulte</surname><given-names>B. A.</given-names></name><name><surname>Wu</surname><given-names>J. Y.</given-names></name><name><surname>Spicer</surname><given-names>S. S.</given-names></name></person-group> (<year>1986</year>). <article-title>GABAergic neurons of rodent brain correspond partially with those staining for glycoconjugate with terminal N-acetylgalactosamine.</article-title>
<source/><italic>J. Neurocytol.</italic>
<volume>15</volume>
<fpage>389</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1007/BF01611440</pub-id>
<pub-id pub-id-type="pmid">2427661</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>A.</given-names></name><name><surname>Khaleel</surname><given-names>H. M.</given-names></name><name><surname>Razak</surname><given-names>K. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Effects of noise-induced hearing loss on parvalbumin and perineuronal net expression in the mouse primary auditory cortex.</article-title>
<source/><italic>Hear. Res.</italic>
<volume>350</volume>
<fpage>82</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.heares.2017.04.015</pub-id>
<pub-id pub-id-type="pmid">28460252</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>T.</given-names></name><name><surname>Musial</surname><given-names>T. F.</given-names></name><name><surname>Marshall</surname><given-names>J. J.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Remmers</surname><given-names>C. L.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Delayed maturation of fast-spiking interneurons is rectified by activation of the TrkB receptor in the mouse model of fragile X syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>11298</fpage>–<lpage>11310</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2893-16.2017</pub-id>
<pub-id pub-id-type="pmid">29038238</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowicka</surname><given-names>D.</given-names></name><name><surname>Soulsby</surname><given-names>S.</given-names></name><name><surname>Skangiel-Kramska</surname><given-names>J.</given-names></name><name><surname>Glazewski</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Parvalbumin-containing neurons, perineuronal nets and experience-dependent plasticity in murine barrel cortex.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>30</volume>
<fpage>2053</fpage>–<lpage>2063</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.06996.x</pub-id>
<pub-id pub-id-type="pmid">20128844</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>R. J.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Petralia</surname><given-names>R. S.</given-names></name><name><surname>Steward</surname><given-names>O.</given-names></name><name><surname>Huganir</surname><given-names>R. L.</given-names></name><name><surname>Worley</surname><given-names>P.</given-names></name></person-group> (<year>1999</year>). <article-title>Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product narp.</article-title>
<source/><italic>Neuron</italic>
<volume>23</volume>
<fpage>309</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80782-5</pub-id>
<pub-id pub-id-type="pmid">10399937</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogiwara</surname><given-names>I.</given-names></name><name><surname>Miyamoto</surname><given-names>H.</given-names></name><name><surname>Morita</surname><given-names>N.</given-names></name><name><surname>Atapour</surname><given-names>N.</given-names></name><name><surname>Mazaki</surname><given-names>E.</given-names></name><name><surname>Inoue</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>27</volume>
<fpage>5903</fpage>–<lpage>5914</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5270-06.2007</pub-id>
<pub-id pub-id-type="pmid">17537961</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oohashi</surname><given-names>T.</given-names></name><name><surname>Edamatsu</surname><given-names>M.</given-names></name><name><surname>Bekku</surname><given-names>Y.</given-names></name><name><surname>Carulli</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>The hyaluronan and proteoglycan link proteins: organizers of the brain extracellular matrix and key molecules for neuronal function and plasticity.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>274</volume>
<fpage>134</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2015.09.010</pub-id>
<pub-id pub-id-type="pmid">26387938</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouda</surname><given-names>L.</given-names></name><name><surname>Druga</surname><given-names>R.</given-names></name><name><surname>Syka</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Changes in parvalbumin immunoreactivity with aging in the central auditory system of the rat.</article-title>
<source/><italic>Exp. Gerontol.</italic>
<volume>43</volume>
<fpage>782</fpage>–<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2008.04.001</pub-id>
<pub-id pub-id-type="pmid">18486384</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palop</surname><given-names>J. J.</given-names></name><name><surname>Chin</surname><given-names>J.</given-names></name><name><surname>Roberson</surname><given-names>E. D.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Thwin</surname><given-names>M. T.</given-names></name><name><surname>Bien-Ly</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of alzheimer’s disease.</article-title>
<source/><italic>Neuron</italic>
<volume>55</volume>
<fpage>697</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.025</pub-id>
<pub-id pub-id-type="pmid">17785178</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papa</surname><given-names>M.</given-names></name><name><surname>De Luca</surname><given-names>C.</given-names></name><name><surname>Petta</surname><given-names>F.</given-names></name><name><surname>Alberghina</surname><given-names>L.</given-names></name><name><surname>Cirillo</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Astrocyte–neuron interplay in maladaptive plasticity.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>42</volume>
<fpage>35</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.01.010</pub-id>
<pub-id pub-id-type="pmid">24509064</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paribello</surname><given-names>C.</given-names></name><name><surname>Tao</surname><given-names>L.</given-names></name><name><surname>Folino</surname><given-names>A.</given-names></name><name><surname>Berry-Kravis</surname><given-names>E.</given-names></name><name><surname>Tranfaglia</surname><given-names>M.</given-names></name><name><surname>Ethell</surname><given-names>I. M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Open-label add-on treatment trial of minocycline in fragile X syndrome.</article-title>
<source/><italic>BMC Neurol.</italic>
<volume>10</volume>:<issue>91</issue>. <pub-id pub-id-type="doi">10.1186/1471-2377-10-91</pub-id>
<pub-id pub-id-type="pmid">20937127</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peress</surname><given-names>N.</given-names></name><name><surname>Perillo</surname><given-names>E.</given-names></name><name><surname>Zucker</surname><given-names>S.</given-names></name></person-group> (<year>1995</year>). <article-title>Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer’s disease and normal brain.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>54</volume>
<fpage>16</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-199501000-00002</pub-id>
<pub-id pub-id-type="pmid">7815076</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzo</surname><given-names>R.</given-names></name><name><surname>Gurgone</surname><given-names>A.</given-names></name><name><surname>Castroflorio</surname><given-names>E.</given-names></name><name><surname>Amendola</surname><given-names>E.</given-names></name><name><surname>Gross</surname><given-names>C.</given-names></name><name><surname>Sassoè-Pognetto</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Lack of Cdkl5 disrupts the organization of excitatory and inhibitory synapses and parvalbumin interneurons in the primary visual cortex.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>10</volume>:<issue>261</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00261</pub-id>
<pub-id pub-id-type="pmid">27965538</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzorusso</surname><given-names>T.</given-names></name><name><surname>Medini</surname><given-names>P.</given-names></name><name><surname>Berardi</surname><given-names>N.</given-names></name><name><surname>Chierzi</surname><given-names>S.</given-names></name><name><surname>Fawcett</surname><given-names>J. W.</given-names></name><name><surname>Maffei</surname><given-names>L.</given-names></name></person-group> (<year>2002</year>). <article-title>Reactivation of ocular dominance plasticity in the adult visual cortex.</article-title>
<source/><italic>Science</italic>
<volume>298</volume>
<fpage>1248</fpage>–<lpage>1251</lpage>. <pub-id pub-id-type="doi">10.1126/science.1072699</pub-id>
<pub-id pub-id-type="pmid">12424383</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollock</surname><given-names>E.</given-names></name><name><surname>Everest</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>A.</given-names></name><name><surname>Poulter</surname><given-names>M. O.</given-names></name></person-group> (<year>2014</year>). <article-title>Metalloproteinase inhibition prevents inhibitory synapse reorganization and seizure genesis.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>70</volume>
<fpage>21</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.06.003</pub-id>
<pub-id pub-id-type="pmid">24946277</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popp</surname><given-names>S.</given-names></name><name><surname>Andersen</surname><given-names>J. S.</given-names></name><name><surname>Maurel</surname><given-names>P.</given-names></name><name><surname>Margolis</surname><given-names>R. U.</given-names></name></person-group> (<year>2003</year>). <article-title>Localization of aggrecan and versican in the developing rat central nervous system.</article-title>
<source/><italic>Dev. Dyn.</italic>
<volume>227</volume>
<fpage>143</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.10282</pub-id>
<pub-id pub-id-type="pmid">12701107</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puel</surname><given-names>J. L.</given-names></name><name><surname>Ruel</surname><given-names>J.</given-names></name><name><surname>Gervais d’Aldin</surname><given-names>C.</given-names></name><name><surname>Pujol</surname><given-names>R.</given-names></name></person-group> (<year>1998</year>). <article-title>Excitotoxicity and repair of cochlear synapses after noise-trauma induced hearing loss.</article-title>
<source/><italic>Neuroreport</italic>
<volume>9</volume>
<fpage>2109</fpage>–<lpage>2114</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199806220-00037</pub-id><pub-id pub-id-type="pmid">9674603</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyka</surname><given-names>M.</given-names></name><name><surname>Wetzel</surname><given-names>C.</given-names></name><name><surname>Aguado</surname><given-names>A.</given-names></name><name><surname>Geissler</surname><given-names>M.</given-names></name><name><surname>Hatt</surname><given-names>H.</given-names></name><name><surname>Faissner</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Chondroitin sulfate proteoglycans regulate astrocyte-dependent synaptogenesis and modulate synaptic activity in primary embryonic hippocampal neurons.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>33</volume>
<fpage>2187</fpage>–<lpage>2202</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07690.x</pub-id>
<pub-id pub-id-type="pmid">21615557</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quattromani</surname><given-names>M. J.</given-names></name><name><surname>Pruvost</surname><given-names>M.</given-names></name><name><surname>Guerreiro</surname><given-names>C.</given-names></name><name><surname>Backlund</surname><given-names>F.</given-names></name><name><surname>Englund</surname><given-names>E.</given-names></name><name><surname>Aspberg</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Extracellular matrix modulation is driven by experience-dependent plasticity during stroke recovery.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>55</volume>
<fpage>2196</fpage>–<lpage>2213</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-017-0461-2</pub-id>
<pub-id pub-id-type="pmid">28290150</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahimi</surname><given-names>S.</given-names></name><name><surname>Sayad</surname><given-names>A.</given-names></name><name><surname>Moslemi</surname><given-names>E.</given-names></name><name><surname>Ghafouri-Fard</surname><given-names>S.</given-names></name><name><surname>Taheri</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Blood assessment of the expression levels of matrix metalloproteinase 9 (MMP9) and its natural inhibitor, TIMP1 genes in Iranian schizophrenic patients.</article-title>
<source/><italic>Metab. Brain Dis.</italic>
<volume>32</volume>
<fpage>1537</fpage>–<lpage>1542</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-017-0043-z</pub-id>
<pub-id pub-id-type="pmid">28578515</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramón</surname><given-names>Y.</given-names></name><name><surname>Cajal</surname><given-names>S.</given-names></name></person-group> (<year>1897</year>). <article-title>Las células de cilindro-eje corto de la capa molecular del cerebro.</article-title>
<source/><italic>Rev. Trim Micrográf.</italic>
<volume>2</volume>
<fpage>105</fpage>–<lpage>127</lpage>.</mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin-Gee</surname><given-names>E. K.</given-names></name><name><surname>McRae</surname><given-names>P. A.</given-names></name><name><surname>Baranov</surname><given-names>E.</given-names></name><name><surname>Rogers</surname><given-names>S.</given-names></name><name><surname>Wandrey</surname><given-names>L.</given-names></name><name><surname>Porter</surname><given-names>B. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Perineuronal net degradation in epilepsy.</article-title>
<source/><italic>Epilepsia</italic>
<volume>56</volume>
<fpage>1124</fpage>–<lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13026</pub-id>
<pub-id pub-id-type="pmid">26032766</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinart</surname><given-names>T.</given-names></name><name><surname>Morawskib</surname><given-names>T.</given-names></name><name><surname>Arendtb</surname><given-names>T.</given-names></name><name><surname>Butz</surname><given-names>T.</given-names></name></person-group> (<year>2003</year>). <article-title>Quantitative microanalysis of perineuronal nets in brain tissue.</article-title>
<source/><italic>Nucl. Instrum. Methods Phys. Res. B</italic>
<volume>210</volume>
<fpage>395</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-583X(03)01041-3</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhard</surname><given-names>S. M.</given-names></name><name><surname>Razak</surname><given-names>K.</given-names></name><name><surname>Ethell</surname><given-names>I. M.</given-names></name></person-group> (<year>2015</year>). <article-title>A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>9</volume>:<issue>280</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00280</pub-id>
<pub-id pub-id-type="pmid">26283917</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberson</surname><given-names>E.</given-names></name><name><surname>Halabisky</surname><given-names>B.</given-names></name><name><surname>Yoo</surname><given-names>J. W.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Chin</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Amyloid-β/fyn–induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer’s Disease.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>700</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4152-10.2011</pub-id><pub-id pub-id-type="pmid">21228179</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>S. J.</given-names></name><name><surname>Wehner</surname><given-names>D. E.</given-names></name><name><surname>Hagerman</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders.</article-title>
<source/><italic>J. Dev. Behav. Pediatr.</italic>
<volume>22</volume>
<fpage>409</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1097/00004703-200112000-00008</pub-id>
<pub-id pub-id-type="pmid">11773805</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>D. C.</given-names></name><name><surname>Benkers</surname><given-names>T. L.</given-names></name><name><surname>Rogers</surname><given-names>S. J.</given-names></name><name><surname>Teale</surname><given-names>P. D.</given-names></name><name><surname>Reite</surname><given-names>M. L.</given-names></name><name><surname>Hagerman</surname><given-names>R. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Auditory evoked magnetic fields in adults with fragile X syndrome.</article-title>
<source/><italic>Neuroreport</italic>
<volume>12</volume>
<fpage>2573</fpage>–<lpage>2576</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-200108080-00056</pub-id>
<pub-id pub-id-type="pmid">11496151</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotschafer</surname><given-names>S.</given-names></name><name><surname>Razak</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Altered auditory processing in a mouse model of fragile X syndrome.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1506</volume>
<fpage>12</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2013.02.038</pub-id>
<pub-id pub-id-type="pmid">23458504</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotschafer</surname><given-names>S.</given-names></name><name><surname>Razak</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Auditory processing in fragile X syndrome.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>19</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00019</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotschafer</surname><given-names>S. E.</given-names></name><name><surname>Trujillo</surname><given-names>M. S.</given-names></name><name><surname>Dansie</surname><given-names>L. E.</given-names></name><name><surname>Ethell</surname><given-names>I. M.</given-names></name><name><surname>Razak</surname><given-names>K. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1439</volume>
<fpage>7</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2011.12.041</pub-id>
<pub-id pub-id-type="pmid">22265702</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiter</surname><given-names>J.</given-names></name><name><surname>Uyling</surname><given-names>H.</given-names></name></person-group> (<year>1987</year>). <article-title>Morphometric and dendritic analysis of fascia dentata granule cells in human again and senile dementia.</article-title>
<source/><italic>Brain Res.</italic>
<volume>402</volume>
<fpage>217</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(87)90028-X</pub-id>
<pub-id pub-id-type="pmid">3828794</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rybakowski</surname><given-names>J. K.</given-names></name><name><surname>Skibinska</surname><given-names>M.</given-names></name><name><surname>Kapelski</surname><given-names>P.</given-names></name><name><surname>Kaczmarek</surname><given-names>L.</given-names></name><name><surname>Hauser</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.</article-title>
<source/><italic>Schizohr. Res.</italic>
<volume>109</volume>
<fpage>90</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2009.02.005</pub-id>
<pub-id pub-id-type="pmid">19264454</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>A.</given-names></name><name><surname>Nakato</surname><given-names>R.</given-names></name><name><surname>Ling</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>X.</given-names></name><name><surname>Hara</surname><given-names>N.</given-names></name><name><surname>Iijima</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Genome-wide target analyses of Otx2 homeoprotein in postnatal cortex.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>11</volume>:<issue>307</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00307</pub-id>
<pub-id pub-id-type="pmid">28620275</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheibel</surname><given-names>A.</given-names></name><name><surname>Tomiyasu</surname><given-names>U.</given-names></name></person-group> (<year>1978</year>). <article-title>Dendritic sprouting in alzheimer’s presenile dementia.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>60</volume>
<fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/0014-4886(78)90164-4</pub-id><pub-id pub-id-type="pmid">350599</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Leigh</surname><given-names>M. J.</given-names></name><name><surname>Adams</surname><given-names>P.</given-names></name><name><surname>Nanakul</surname><given-names>R.</given-names></name><name><surname>Chechi</surname><given-names>T.</given-names></name><name><surname>Olichney</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Electrocortical changes associated with minocycline treatment in fragile X syndrome.</article-title>
<source/><italic>J. Psychopharmacol.</italic>
<volume>27</volume>
<fpage>956</fpage>–<lpage>963</lpage>. <pub-id pub-id-type="doi">10.1177/0269881113494105</pub-id>
<pub-id pub-id-type="pmid">23981511</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwaller</surname><given-names>B.</given-names></name><name><surname>Tetko</surname><given-names>I. V.</given-names></name><name><surname>Tandon</surname><given-names>P.</given-names></name><name><surname>Silveira</surname><given-names>D. C.</given-names></name><name><surname>Vreugdenhil</surname><given-names>M.</given-names></name><name><surname>Henzi</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>25</volume>
<fpage>650</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2003.12.006</pub-id>
<pub-id pub-id-type="pmid">15080894</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheppard</surname><given-names>A. M.</given-names></name><name><surname>Hamilton</surname><given-names>S. K.</given-names></name><name><surname>Pearlman</surname><given-names>A. L.</given-names></name></person-group> (<year>1991</year>). <article-title>Changes in the distribution of extracellular matrix components accompany early morphogenetic events of mammalian cortical development.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>11</volume>
<fpage>3928</fpage>–<lpage>3942</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.11-12-03928.1991</pub-id>
<pub-id pub-id-type="pmid">1720815</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>L.</given-names></name><name><surname>Back</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>A ‘GAG’ reflex prevents repair of the damage CNS.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>31</volume>
<fpage>44</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2007.11.001</pub-id>
<pub-id pub-id-type="pmid">18063497</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>D.</given-names></name><name><surname>Featherstone</surname><given-names>R.</given-names></name><name><surname>Naschek</surname><given-names>M.</given-names></name><name><surname>Nam</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>A.</given-names></name><name><surname>Wright</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2017a</year>). <article-title>GABA-B agonist baclofen normalizes auditory-evoked neural oscillations and behavioral deficits in the <italic>Fmr1</italic> knockout mouse model of Fragile X Syndrome.</article-title>
<source/><italic>eNeuro</italic>
<volume>4</volume> ENEURO.0380-16.2017. <pub-id pub-id-type="doi">10.1523/ENEURO.0380-16.2017</pub-id>
<pub-id pub-id-type="pmid">28451631</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>D.</given-names></name><name><surname>Oranje</surname><given-names>B.</given-names></name><name><surname>Razak</surname><given-names>K. A.</given-names></name><name><surname>Siegel</surname><given-names>S. J.</given-names></name><name><surname>Schmid</surname><given-names>S.</given-names></name></person-group> (<year>2017b</year>). <article-title>Sensory processing in autism spectrum disorders and Fragile X syndrome—From the clinic to animal models.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>76</volume>
<fpage>235</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.05.029</pub-id>
<pub-id pub-id-type="pmid">27235081</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloviter</surname><given-names>R. S.</given-names></name><name><surname>Sollas</surname><given-names>A. L.</given-names></name><name><surname>Barbaro</surname><given-names>N. M.</given-names></name><name><surname>Laxer</surname><given-names>K. D.</given-names></name></person-group> (<year>1991</year>). <article-title>Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>308</volume>
<fpage>381</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903080306</pub-id>
<pub-id pub-id-type="pmid">1865007</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>A. C.</given-names></name><name><surname>Scofield</surname><given-names>M. D.</given-names></name><name><surname>Kalivas</surname><given-names>P. W.</given-names></name></person-group> (<year>2015</year>). <article-title>The tetrapartite synapse: extracellular matrix remodeling contributes to corticoaccumbens plasticity underlying drug addiction.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1628</volume>
<fpage>29</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2015.03.027</pub-id>
<pub-id pub-id-type="pmid">25838241</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohal</surname><given-names>V. S.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Yizhar</surname><given-names>O.</given-names></name><name><surname>Deisseroth</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Parvalbumin neurons and gamma rhythms enhance cortical circuit performance.</article-title>
<source/><italic>Nature</italic>
<volume>459</volume>
<fpage>698</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1038/nature07991</pub-id>
<pub-id pub-id-type="pmid">19396159</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorg</surname><given-names>B. A.</given-names></name><name><surname>Berretta</surname><given-names>S.</given-names></name><name><surname>Blacktop</surname><given-names>J. M.</given-names></name><name><surname>Fawcett</surname><given-names>J. W.</given-names></name><name><surname>Kitagawa</surname><given-names>H.</given-names></name><name><surname>Kwok</surname><given-names>J. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Casting a wide net: role of perineuronal nets in neural plasticity.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>11459</fpage>–<lpage>11468</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2351-16.2016</pub-id>
<pub-id pub-id-type="pmid">27911749</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steullet</surname><given-names>P.</given-names></name><name><surname>Cabungcal</surname><given-names>J. H.</given-names></name><name><surname>Cuénod</surname><given-names>M.</given-names></name><name><surname>Do</surname><given-names>K. Q.</given-names></name></person-group> (<year>2014</year>). <article-title>Fast oscillatory activity in the anterior cingulate cortex: dopaminergic modulation and effect of perineuronal net loss.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>244</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00244</pub-id>
<pub-id pub-id-type="pmid">25191228</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stohs</surname><given-names>W.</given-names></name><name><surname>Bagchi</surname><given-names>D.</given-names></name></person-group> (<year>1995</year>). <article-title>Oxidative mechanisms in the toxicity of metal ions.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>18</volume>
<fpage>321</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1016/0891-5849(94)00159-H</pub-id><pub-id pub-id-type="pmid">7744317</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiyama</surname><given-names>S.</given-names></name><name><surname>Di Nardo</surname><given-names>A. A.</given-names></name><name><surname>Aizawa</surname><given-names>S.</given-names></name><name><surname>Matsuo</surname><given-names>I.</given-names></name><name><surname>Volovitch</surname><given-names>M.</given-names></name><name><surname>Prochiantz</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity.</article-title>
<source/><italic>Cell</italic>
<volume>134</volume>
<fpage>508</fpage>–<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.05.054</pub-id>
<pub-id pub-id-type="pmid">18692473</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Halabisky</surname><given-names>B.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Palop</surname><given-names>J. J.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Mucke</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer’s Disease.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>5</volume>
<fpage>624</fpage>–<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2009.10.003</pub-id>
<pub-id pub-id-type="pmid">19951690</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suttkus</surname><given-names>A.</given-names></name><name><surname>Rohn</surname><given-names>S.</given-names></name><name><surname>Jäger</surname><given-names>C.</given-names></name><name><surname>Arendt</surname><given-names>T.</given-names></name><name><surname>Morawski</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress.</article-title>
<source/><italic>Am. J. Neurodegener. Dis.</italic>
<volume>1</volume>
<fpage>122</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="pmid">23383386</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suttkus</surname><given-names>A.</given-names></name><name><surname>Rohn</surname><given-names>S.</given-names></name><name><surname>Weigel</surname><given-names>S.</given-names></name><name><surname>Glöckner</surname><given-names>P.</given-names></name><name><surname>Arendt</surname><given-names>T.</given-names></name><name><surname>Morawski</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress.</article-title>
<source/><italic>Cell Death Dis.</italic>
<volume>5</volume>:<issue>e1119</issue>. <pub-id pub-id-type="doi">10.1038/cddis.2014.25</pub-id>
<pub-id pub-id-type="pmid">24625978</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syka</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Plastic changes in the central auditory system after hearing loss, restoration of function, and during learning.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>82</volume>
<fpage>601</fpage>–<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00002.2002</pub-id>
<pub-id pub-id-type="pmid">12087130</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosic</surname><given-names>M.</given-names></name><name><surname>Ott</surname><given-names>J.</given-names></name><name><surname>Barral</surname><given-names>S.</given-names></name><name><surname>Bovet</surname><given-names>P.</given-names></name><name><surname>Deppen</surname><given-names>P.</given-names></name><name><surname>Gheorghita</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>79</volume>
<fpage>586</fpage>–<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1086/507566</pub-id>
<pub-id pub-id-type="pmid">16909399</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trujillo</surname><given-names>M.</given-names></name><name><surname>Razak</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Altered cortical spectrotemporal processing with age-related hearing loss.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>110</volume>
<fpage>2873</fpage>–<lpage>2886</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00423.2013</pub-id>
<pub-id pub-id-type="pmid">24068755</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>H.</given-names></name><name><surname>Suemitsu</surname><given-names>S.</given-names></name><name><surname>Okamoto</surname><given-names>M.</given-names></name><name><surname>Matsumoto</surname><given-names>Y.</given-names></name><name><surname>Ishihara</surname><given-names>T.</given-names></name></person-group> (<year>2017a</year>). <article-title>Parvalbumin neurons and perineuronal nets in the mouse prefrontal cortex.</article-title>
<source/><italic>Neuroscience</italic>
<volume>343</volume>
<fpage>115</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.11.035</pub-id>
<pub-id pub-id-type="pmid">27923740</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>H.</given-names></name><name><surname>Suemitsu</surname><given-names>S.</given-names></name><name><surname>Okamoto</surname><given-names>M.</given-names></name><name><surname>Matsumoto</surname><given-names>Y.</given-names></name><name><surname>Ishihara</surname><given-names>T.</given-names></name></person-group> (<year>2017b</year>). <article-title>Sensory experience-dependent formation of perineuronal nets and expression of Cat-315 immunoreactive components in the mouse somatosensory cortex.</article-title>
<source/><italic>Neuroscience</italic>
<volume>355</volume>
<fpage>161</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.04.041</pub-id>
<pub-id pub-id-type="pmid">28495333</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>H.</given-names></name><name><surname>Takao</surname><given-names>K.</given-names></name><name><surname>Suemitsu</surname><given-names>S.</given-names></name><name><surname>Murakami</surname><given-names>S.</given-names></name><name><surname>Kitamura</surname><given-names>N.</given-names></name><name><surname>Wani</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2017c</year>). <article-title>Age-dependent and region-specific alteration of parvalbumin neurons and perineuronal nets in the mouse cerebral cortex.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>112</volume>
<fpage>59</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2017.11.001</pub-id>
<pub-id pub-id-type="pmid">29126935</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlhaas</surname><given-names>P. J.</given-names></name><name><surname>Roux</surname><given-names>F.</given-names></name><name><surname>Singer</surname><given-names>W.</given-names></name><name><surname>Haenschel</surname><given-names>C.</given-names></name><name><surname>Sireteanu</surname><given-names>R.</given-names></name><name><surname>Rodriguez</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>The development of neural synchrony reflects late maturation and restructuring of functional networks in humans.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>9866</fpage>–<lpage>9871</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0900390106</pub-id>
<pub-id pub-id-type="pmid">19478071</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Molen</surname><given-names>M. J.</given-names></name><name><surname>Van der Molen</surname><given-names>M. W.</given-names></name><name><surname>Ridderinkhof</surname><given-names>K. R.</given-names></name><name><surname>Hamel</surname><given-names>B. C.</given-names></name><name><surname>Curfs</surname><given-names>L. M.</given-names></name><name><surname>Ramakers</surname><given-names>G. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Auditory and visual cortical activity during selective attention in fragile X syndrome: a cascade of processing deficiencies.</article-title>
<source/><italic>Clin. Neurophysiol.</italic>
<volume>123</volume>
<fpage>720</fpage>–<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinph.2011.08.023</pub-id>
<pub-id pub-id-type="pmid">21958658</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varadarajan</surname><given-names>S.</given-names></name><name><surname>Yatin</surname><given-names>S.</given-names></name><name><surname>Aksenova</surname><given-names>M.</given-names></name><name><surname>Butterfield</surname><given-names>D. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Alzheimer’s amyloid β-peptide-associated free radical oxidative stress and neurotoxicity.</article-title>
<source/><italic>J. Struct. Biol.</italic>
<volume>130</volume>
<fpage>184</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1006/jsbi.2000.4274</pub-id>
<pub-id pub-id-type="pmid">10940225</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>A. J.</given-names></name><name><surname>Pieretti</surname><given-names>M.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><name><surname>Fu</surname><given-names>Y. H.</given-names></name><name><surname>Kuhl</surname><given-names>D. P.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1991</year>). <article-title>Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.</article-title>
<source/><italic>Cell</italic>
<volume>65</volume>
<fpage>905</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90397-H</pub-id>
<pub-id pub-id-type="pmid">1710175</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>D. W.</given-names></name><name><surname>Austin</surname><given-names>M. C.</given-names></name><name><surname>Pierri</surname><given-names>J. N.</given-names></name><name><surname>Sampson</surname><given-names>A. R.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Decreased GAD67 mRNA expression in a subset of prefrontal cortical GABA neurons in subjects with schizophrenia.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>57</volume>
<fpage>237</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.57.3.237</pub-id><pub-id pub-id-type="pmid">10711910</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Fawcett</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>The perineuronal net and the control of CNS plasticity.</article-title>
<source/><italic>Cell Tissue Res.</italic>
<volume>349</volume>
<fpage>147</fpage>–<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-012-1375-y</pub-id>
<pub-id pub-id-type="pmid">22437874</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Ethridge</surname><given-names>L. E.</given-names></name><name><surname>Mosconi</surname><given-names>M. W.</given-names></name><name><surname>White</surname><given-names>S. P.</given-names></name><name><surname>Binder</surname><given-names>D. K.</given-names></name><name><surname>Pedapati</surname><given-names>E. V.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome.</article-title>
<source/><italic>J. Neurodev. Disord.</italic>
<volume>9</volume>:<issue>11</issue>. <pub-id pub-id-type="doi">10.1186/s11689-017-9191-z</pub-id>
<pub-id pub-id-type="pmid">28316753</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegner</surname><given-names>F.</given-names></name><name><surname>Härtig</surname><given-names>W.</given-names></name><name><surname>Bringmann</surname><given-names>A.</given-names></name><name><surname>Grosche</surname><given-names>J.</given-names></name><name><surname>Wohlfarth</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Diffuse perineuronal nets and modified pyramidal cells immunoreactive for glutamate and the GABA A receptor α1 subunit form a unique entity in rat cerebral cortex.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>184</volume>
<fpage>705</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-4886(03)00313-3</pub-id>
<pub-id pub-id-type="pmid">14769362</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>T. H.</given-names></name><name><surname>Afroz</surname><given-names>S.</given-names></name><name><surname>Reinhard</surname><given-names>S. M.</given-names></name><name><surname>Palacios</surname><given-names>A. R.</given-names></name><name><surname>Tapia</surname><given-names>K.</given-names></name><name><surname>Binder</surname><given-names>D. K.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Genetic reduction of matrix metalloproteinase-9 promotes formation of perineuronal nets around parvalbumin-expressing interneurons and normalizes auditory cortex responses in developing <italic>Fmr1</italic> knock-out mice.</article-title>
<source/><italic>Cereb. Cortex</italic>
<volume>13</volume>
<fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhx258</pub-id>
<pub-id pub-id-type="pmid">29040407</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilczynski</surname><given-names>G. M.</given-names></name><name><surname>Konopacki</surname><given-names>F. A.</given-names></name><name><surname>Wilczek</surname><given-names>E.</given-names></name><name><surname>Lasiecka</surname><given-names>Z.</given-names></name><name><surname>Gorlewicz</surname><given-names>A.</given-names></name><name><surname>Michaluk</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Important role of matrix metalloproteinase 9 in epileptogenesis.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>180</volume>
<fpage>1021</fpage>–<lpage>1035</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200708213</pub-id>
<pub-id pub-id-type="pmid">18332222</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Murphy</surname><given-names>T. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Prolonged deficits in parvalbumin neuron stimulation-evoked network activity despite recovery of dendritic structure and excitability in the somatosensory cortex following global ischemia in mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>14890</fpage>–<lpage>14900</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1775-14.2014</pub-id>
<pub-id pub-id-type="pmid">25378156</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>J.</given-names></name><name><surname>Jinno</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Molecular heterogeneity of aggrecan-based perineuronal nets around five subclasses of parvalbumin-expressing neurons in the mouse hippocampus.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>525</volume>
<fpage>1234</fpage>–<lpage>1249</lpage>. <pub-id pub-id-type="doi">10.1002/cne.24132</pub-id>
<pub-id pub-id-type="pmid">27718219</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Lecticans: organizers of the brain extracellular matrix.</article-title>
<source/><italic>Cell. Mol. Life Sci.</italic>
<volume>57</volume>
<fpage>276</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1007/PL00000690</pub-id>
<pub-id pub-id-type="pmid">10766023</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamori</surname><given-names>H.</given-names></name><name><surname>Hashimoto</surname><given-names>R.</given-names></name><name><surname>Ishima</surname><given-names>T.</given-names></name><name><surname>Kishi</surname><given-names>F.</given-names></name><name><surname>Yasuda</surname><given-names>Y.</given-names></name><name><surname>Ohi</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>556</volume>
<fpage>37</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.09.059</pub-id>
<pub-id pub-id-type="pmid">24141084</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Leonard</surname><given-names>S.</given-names></name><name><surname>Reddy</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Altered glutathione redox state in schizophrenia.</article-title>
<source/><italic>Dis. Markers</italic>
<volume>22</volume>
<fpage>83</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1155/2006/248387</pub-id><pub-id pub-id-type="pmid">16410648</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yutsudo</surname><given-names>N.</given-names></name><name><surname>Kitagawa</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Involvement of chondroitin 6-sulfation in temporal lobe epilepsy.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>274</volume>
<fpage>126</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2015.07.009</pub-id>
<pub-id pub-id-type="pmid">26231575</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Chang</surname><given-names>M.</given-names></name><name><surname>Hansen</surname><given-names>C. N.</given-names></name><name><surname>Basso</surname><given-names>D. M.</given-names></name><name><surname>Noble-Haeusslein</surname><given-names>L. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.</article-title>
<source/><italic>Neurotherapeutics</italic>
<volume>8</volume>
<fpage>206</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-011-0038-0</pub-id>
<pub-id pub-id-type="pmid">21455784</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<title>Abbreviations</title>
<def-list id="DL1">
<def-item>
<term>AD</term>
<def>
<p>Alzheimer’s disease</p>
</def>
</def-item>
<def-item>
<term>ADAMTs</term>
<def>
<p>a disintegrin and metalloproteinase with thrombospondin motif</p>
</def>
</def-item>
<def-item>
<term>chABC</term>
<def>
<p>chondroitinase ABC</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p>central nervous system</p>
</def>
</def-item>
<def-item>
<term>CSPG</term>
<def>
<p>chondroitin sulfate proteoglycan</p>
</def>
</def-item>
<def-item>
<term>E</term>
<def>
<p>embryonic</p>
</def>
</def-item>
<def-item>
<term>E/I</term>
<def>
<p>excitatory/inhibitory</p>
</def>
</def-item>
<def-item>
<term>ECM</term>
<def>
<p>extracellular matrix</p>
</def>
</def-item>
<def-item>
<term>EEG</term>
<def>
<p>electroencephalography</p>
</def>
</def-item>
<def-item>
<term>FXS</term>
<def>
<p>Fragile X Syndrome</p>
</def>
</def-item>
<def-item>
<term>GAD</term>
<def>
<p>glutamate decarboxylase</p>
</def>
</def-item>
<def-item>
<term>GAG</term>
<def>
<p>glycosaminoglycan</p>
</def>
</def-item>
<def-item>
<term>GCL</term>
<def>
<p>glutamate cysteine ligase</p>
</def>
</def-item>
<def-item>
<term>GSH</term>
<def>
<p>glutathione</p>
</def>
</def-item>
<def-item>
<term>HAS</term>
<def>
<p>hyaluronan synthase</p>
</def>
</def-item>
<def-item>
<term>MMP-9</term>
<def>
<p>matrix metalloproteinase-9</p>
</def>
</def-item>
<def-item>
<term>NGF</term>
<def>
<p>nerve growth factor</p>
</def>
</def-item>
<def-item>
<term>Otx2</term>
<def>
<p>orthodenticle homeoprotein 2</p>
</def>
</def-item>
<def-item>
<term>P</term>
<def>
<p>postnatal</p>
</def>
</def-item>
<def-item>
<term>PNN</term>
<def>
<p>perineuronal net</p>
</def>
</def-item>
<def-item>
<term>PV</term>
<def>
<p>parvalbumin</p>
</def>
</def-item>
<def-item>
<term>TIMPs</term>
<def>
<p>tissue inhibitor of MMPs</p>
</def>
</def-item>
<def-item>
<term>WFA</term>
<def>
<p>wisteria floribunda agglutinin.</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>